{"meta":{"query_hash":"94f1ed7573a0","filters":{"venue":"Journal of Dermatological Treatment"},"cohort_total":88,"direct_labels_cover":0,"predictions_cover":88,"exported":88,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/94f1ed7573a0","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Dermatological+Treatment"},"results":[{"id":"W1687877434","doi":"10.3109/09546634.2015.1034081","title":"Routes of drug delivery into the nail apparatus: Implications for the efficacy of topical nail solutions in onychomycosis","year":2015,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Nail (fastener); Nail plate; Nail matrix; Medicine; Antifungal; Nail disease; Antifungal drug; Dermatology; Materials science; Paronychia","score_opus":0.08163142648153489,"score_gpt":0.3448682704347608,"score_spread":0.26323684395322594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1687877434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5684621,0.34187108,0.026339756,0.01181183,0.0014259608,0.00037052255,0.0001840577,0.00024665924,0.04928808],"genre_scores_gemma":[0.92795384,0.06085287,0.004823207,0.00049000303,0.00023732513,0.00006494169,0.000028931538,0.000048177517,0.0055007027],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99937505,0.00028494094,0.00004559877,0.00005428871,0.00015018253,0.00008987278],"domain_scores_gemma":[0.99915946,0.00034682397,0.00021531103,0.00004423091,0.000158685,0.000075551805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086802815,0.00038359445,0.00047596454,0.0006628332,0.00050344353,0.0024979715,0.0005712988,0.00087178213,0.0049484298],"category_scores_gemma":[0.0016174136,0.0002698468,0.00047832323,0.00025417167,0.00081427663,0.0022605127,0.00047052559,0.0010995928,0.0008223327],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036869487,0.0015506586,0.0076861153,0.003139692,0.00014926348,0.004380459,0.00056704646,0.0040188935,0.62746674,0.037642784,0.0034327768,0.3062786],"study_design_scores_gemma":[0.0005774718,0.0121271135,0.061688904,0.0021524078,0.0005854892,0.027617315,0.0040483144,0.01589206,0.72965217,0.033901982,0.111515775,0.00024109524],"about_ca_topic_score_codex":0.0013611758,"about_ca_topic_score_gemma":0.0012077298,"teacher_disagreement_score":0.0049484298,"about_ca_system_score_codex":0.0012595202,"about_ca_system_score_gemma":0.0008810842,"threshold_uncertainty_score":0.016554177},"labels":[],"label_agreement":null},{"id":"W1964158557","doi":"10.3109/09546634.2013.852297","title":"Topical antibiotic monotherapy prescribing practices in acne vulgaris","year":2013,"lang":"en","type":"editorial","venue":"Journal of Dermatological Treatment","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Memorial University of Newfoundland","keywords":"Medicine; Acne; Medical prescription; Antibiotics; Clindamycin; Specialty; Propionibacterium acnes; Dermatology; Erythromycin; Dosing; Internal medicine; Family medicine; Pharmacology","score_opus":0.04477316509080872,"score_gpt":0.35397325429949505,"score_spread":0.30920008920868636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964158557","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2194802,0.5303027,0.0013710938,0.07412799,0.14896153,0.00018339217,0.002354417,0.00025035403,0.02296832],"genre_scores_gemma":[0.39123008,0.29508972,0.002183308,0.021053568,0.28146702,0.00017140273,0.0012884017,0.00008939736,0.007427166],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99807125,0.0006061131,0.0003684173,0.00020761909,0.0006767125,0.00006988395],"domain_scores_gemma":[0.99144226,0.0044800728,0.002116405,0.000111232104,0.0015494061,0.00030054015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013277277,0.00027176412,0.00053689576,0.0014782646,0.00033681083,0.0010377958,0.00045035596,0.0011131713,0.0016510693],"category_scores_gemma":[0.007157551,0.00019933283,0.0003074252,0.0015186751,0.00039690142,0.00075687846,0.00022784619,0.0007951141,0.0004812966],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007103229,0.00034349074,0.250327,0.0070521776,0.0002724306,0.00421067,0.0011284528,0.00021143431,0.0014145252,0.0002571187,0.46487355,0.26919875],"study_design_scores_gemma":[0.00018580229,0.0006348529,0.7015367,0.0061706905,0.0005396121,0.014095093,0.0015972519,0.0010185166,0.000976795,0.00035652323,0.27283192,0.000056248202],"about_ca_topic_score_codex":0.0014185132,"about_ca_topic_score_gemma":0.0027827146,"teacher_disagreement_score":0.0016510693,"about_ca_system_score_codex":0.0003825214,"about_ca_system_score_gemma":0.0005818185,"threshold_uncertainty_score":0.007021785},"labels":[],"label_agreement":null},{"id":"W1986252942","doi":"10.3109/09546634.2014.975671","title":"A retrospective chart review of the clinical efficacy of Nd:YAG 1064-nm laser for toenail onychomycosis","year":2014,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Nail (fastener); Debridement (dental); Dermatology; Dermatophyte; Retrospective cohort study; Surgery; Regimen; Terbinafine; Nail plate; Nail disease; Clinical efficacy; Laser therapy; Dentistry; Antifungal; Laser; Complication; Itraconazole","score_opus":0.05872623661093781,"score_gpt":0.3834644224662124,"score_spread":0.3247381858552746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986252942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886856,0.0059401146,0.00040124214,0.00007916282,0.000024832412,0.00028145695,0.0020876238,0.00002810566,0.0024717574],"genre_scores_gemma":[0.9959739,0.001876069,0.00035811635,0.000110037836,0.000025316329,0.00008401572,0.0011442435,0.0000069158473,0.0004214086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929523,0.0001299365,0.00019782419,0.00010414665,0.00020580627,0.00006694978],"domain_scores_gemma":[0.9960764,0.001177258,0.0017126577,0.0002012298,0.00061709824,0.00021536657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000710693,0.00016706946,0.0004200199,0.0014189442,0.00040566697,0.00037856787,0.00025969572,0.0002577033,0.0017819894],"category_scores_gemma":[0.0022340892,0.00018752419,0.00031963052,0.0018172485,0.0002696966,0.0003349894,0.00020856784,0.00024042845,0.00032995667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031493558,0.0002302319,0.97102576,0.0005319106,0.00008577038,0.0073479987,0.0003658461,0.00006639081,0.0013539845,0.00008146856,0.0011746889,0.017420882],"study_design_scores_gemma":[0.000035067205,0.00086967665,0.9686885,0.00012541018,0.00012474174,0.02418157,0.0006953204,0.00013910254,0.0010927592,0.000028808,0.003997833,0.000021292188],"about_ca_topic_score_codex":0.002665063,"about_ca_topic_score_gemma":0.0035457418,"teacher_disagreement_score":0.002665063,"about_ca_system_score_codex":0.00059558585,"about_ca_system_score_gemma":0.00092594937,"threshold_uncertainty_score":0.0059613585},"labels":[],"label_agreement":null},{"id":"W1992810588","doi":"10.3109/09546634.2012.703308","title":"Evidence-based optimal fluconazole dosing regimen for onychomycosis treatment","year":2012,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Fluconazole; Medicine; Terbinafine; Itraconazole; Dosing; Regimen; Dermatophyte; Clinical trial; Dermatology; Mycosis; Cure rate; Surgery; Internal medicine; Antifungal","score_opus":0.3038098313424347,"score_gpt":0.4265748797926199,"score_spread":0.12276504845018515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992810588","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019664473,0.998965,0.00009501584,0.00017494065,0.00007913978,0.000029938923,0.000040845236,0.000004202575,0.0004143517],"genre_scores_gemma":[0.0031024595,0.9957004,0.0006997226,0.00017938421,0.000060310944,0.000044813987,0.000090998314,0.0000015357964,0.00012026139],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9989272,0.0003110754,0.00033945235,0.000086537366,0.00029540603,0.00004026887],"domain_scores_gemma":[0.99853265,0.0007974197,0.00039652738,0.000023060398,0.00021668995,0.00003373779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015404108,0.0009805486,0.003029959,0.0027870636,0.00026341106,0.0011209489,0.002043313,0.0016223637,0.0051673097],"category_scores_gemma":[0.00372347,0.0003307548,0.0016375289,0.0029797377,0.0003153398,0.0009893846,0.0004513231,0.0009598987,0.000763124],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030088873,0.000111732064,0.0003627245,0.3179354,0.0013515308,0.00023691266,0.00004401955,0.0003324106,0.000608851,0.0010433716,0.012189221,0.66548294],"study_design_scores_gemma":[0.001106776,0.00073522085,0.008614337,0.5407721,0.01850384,0.0037438108,0.00024786848,0.0007541765,0.0017023572,0.0032777374,0.42044708,0.000094667615],"about_ca_topic_score_codex":0.0020253335,"about_ca_topic_score_gemma":0.003446158,"teacher_disagreement_score":0.0051673097,"about_ca_system_score_codex":0.0012270159,"about_ca_system_score_gemma":0.0027062383,"threshold_uncertainty_score":0.01728636},"labels":[],"label_agreement":null},{"id":"W1995845116","doi":"10.1080/09546630510011801","title":"Evaluation of the efficacy of topical caffeine in the treatment of psoriasis vulgaris","year":2005,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Caffeine; Psoriasis; Placebo; Psoriasis Area and Severity Index; Internal medicine; Gastroenterology; Dermatology; Pathology","score_opus":0.05697133314208078,"score_gpt":0.3086893164628903,"score_spread":0.2517179833208095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995845116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873635,0.01123107,0.00016802552,0.00013592467,0.00006848246,0.0003174943,0.000075803684,0.000016349934,0.0006231856],"genre_scores_gemma":[0.99291307,0.0051341606,0.0006521952,0.00015790803,0.00024287388,0.00028459085,0.00013245083,0.0000048957268,0.0004778133],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99943227,0.00029375107,0.00005455949,0.00007256248,0.00009829694,0.00004852857],"domain_scores_gemma":[0.9993511,0.00022193951,0.00016141745,0.0000319103,0.00006781967,0.00016581066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008539573,0.00043986263,0.001238684,0.00031212324,0.0003210326,0.00027560737,0.00040278924,0.00070071244,0.0022790486],"category_scores_gemma":[0.0009483728,0.00023138706,0.00055312994,0.00022317111,0.0005143635,0.00030888297,0.00021243903,0.00077192776,0.0002597262],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5991218,0.045710176,0.007891651,0.004606106,0.0014733431,0.00048299663,0.0002855133,0.0006346202,0.12540786,0.0001586919,0.0008909202,0.21333624],"study_design_scores_gemma":[0.09742454,0.8527169,0.03367239,0.00013269883,0.0010469751,0.0006196512,0.00013605182,0.0004793423,0.011377361,0.00006446786,0.002295056,0.00003457782],"about_ca_topic_score_codex":0.00027650883,"about_ca_topic_score_gemma":0.0004238094,"teacher_disagreement_score":0.0022790486,"about_ca_system_score_codex":0.00020652071,"about_ca_system_score_gemma":0.00036062597,"threshold_uncertainty_score":0.0076241493},"labels":[],"label_agreement":null},{"id":"W2017932566","doi":"10.3109/09546634.2013.865009","title":"The 5-point Investigator’s Global Assessment (IGA) Scale: A modified tool for evaluating plaque psoriasis severity in clinical trials","year":2013,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":261,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Secukinumab; Medicine; Psoriasis Area and Severity Index; Psoriasis; Clinical endpoint; Clinical trial; Surrogate endpoint; Internal medicine; Dermatology; Immunology; Psoriatic arthritis","score_opus":0.3175616168721397,"score_gpt":0.490082295512084,"score_spread":0.1725206786399443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017932566","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14686997,0.11843611,0.44880995,0.025117168,0.010449428,0.12997566,0.03495005,0.004488809,0.080902815],"genre_scores_gemma":[0.3706282,0.014434719,0.41896448,0.007912165,0.0025241582,0.1668263,0.013565854,0.0005644833,0.004579679],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.6538248,0.2750401,0.03412322,0.0038065857,0.031835612,0.0013696562],"domain_scores_gemma":[0.8055995,0.10291822,0.04742453,0.00853795,0.032188028,0.0033316826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.17429298,0.0021778387,0.00396733,0.007700171,0.0008702368,0.0035526594,0.0024200722,0.0027437026,0.005129846],"category_scores_gemma":[0.19152467,0.0006959514,0.0058362805,0.008267703,0.0020502235,0.002697296,0.0036109039,0.004170541,0.0019805895],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022851454,0.0019001513,0.10734727,0.02584467,0.012818263,0.0004390236,0.0018741126,0.007650347,0.0057778745,0.014243568,0.13778685,0.6614665],"study_design_scores_gemma":[0.029889109,0.03488789,0.51113427,0.01723745,0.0063007553,0.0036190613,0.0013485155,0.026660237,0.0056557064,0.032812703,0.32930696,0.0011472908],"about_ca_topic_score_codex":0.0003908607,"about_ca_topic_score_gemma":0.00078980764,"teacher_disagreement_score":0.17429298,"about_ca_system_score_codex":0.0021369888,"about_ca_system_score_gemma":0.0039769965,"threshold_uncertainty_score":0.9217604},"labels":[],"label_agreement":null},{"id":"W2050849983","doi":"10.3109/09546634.2011.607795","title":"A randomized study comparing the combination of nbUVB and etanercept to etanercept monotherapy in patients with psoriasis who do not exhibit an excellent response after 12 weeks of etanercept","year":2011,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Guenther Dermatology Research Centre; Innovaderm (Canada); Mediprobe Research (Canada); Lynde Centre for Dermatology","funders":"","keywords":"Etanercept; Medicine; Psoriasis; Dermatology; Combination therapy; Ultraviolet b; Randomized controlled trial; Internal medicine; Tumor necrosis factor alpha","score_opus":0.03614645644071029,"score_gpt":0.2553173164820604,"score_spread":0.2191708600413501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050849983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98839694,0.002055734,0.00077292987,0.0005455523,0.0008134677,0.005560143,0.00047074445,0.00007101673,0.001313521],"genre_scores_gemma":[0.98455197,0.0014915161,0.0022996974,0.00095136027,0.0007991082,0.0074099153,0.0005325046,0.000015991363,0.0019479224],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973073,0.0017169449,0.0002012039,0.00033975753,0.0001793498,0.00025540192],"domain_scores_gemma":[0.9967861,0.0012327712,0.0006183217,0.0002724514,0.00022198084,0.0008683544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032097981,0.0016098805,0.004556077,0.0006909262,0.0007133982,0.001305723,0.0012043179,0.0023022252,0.008666903],"category_scores_gemma":[0.0039345417,0.0012838244,0.0024673773,0.00058931694,0.0018076478,0.0013106482,0.0006533923,0.0027080958,0.0011736914],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9837255,0.009450908,0.00033957866,0.00021012913,0.00053267163,0.000023561497,0.000025050029,0.00010654637,0.00108315,0.000044341068,0.00016100515,0.0042977254],"study_design_scores_gemma":[0.9431415,0.055802725,0.00047103246,0.00001063305,0.00020546908,0.000013794799,0.000008748153,0.000133459,0.00006577146,0.000029647386,0.00011157277,0.000005538119],"about_ca_topic_score_codex":0.0010012424,"about_ca_topic_score_gemma":0.0021795284,"teacher_disagreement_score":0.008666903,"about_ca_system_score_codex":0.0009548191,"about_ca_system_score_gemma":0.0021209498,"threshold_uncertainty_score":0.028993666},"labels":[],"label_agreement":null},{"id":"W2061436092","doi":"10.3109/09546634.2011.643221","title":"A fixed-dose combination of adapalene 0.1%–BPO 2.5% allows an early and sustained improvement in quality of life and patient treatment satisfaction in severe acne","year":2011,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"XLV Diagnostics (Canada)","funders":"Galderma","keywords":"Medicine; Acne; Adapalene; Benzoyl peroxide; Quality of life (healthcare); Patient satisfaction; Randomized controlled trial; Regimen; Acne treatment; Dermatology Life Quality Index; Combination therapy; Minimal clinically important difference; Dermatology; Internal medicine; Physical therapy; Surgery; Nursing","score_opus":0.045473564241038655,"score_gpt":0.2971984006147316,"score_spread":0.2517248363736929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061436092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715626,0.0017039664,0.00036838403,0.00005728441,0.000035833586,0.00011484937,0.00007223357,0.000034904533,0.00045639268],"genre_scores_gemma":[0.9974717,0.0008767885,0.0006637005,0.000040426286,0.000048574646,0.000108472625,0.000104064326,0.0000074947757,0.00067875296],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998437,0.000049349826,0.0000104196515,0.000030434267,0.000032676184,0.000033390676],"domain_scores_gemma":[0.9998869,0.000030102088,0.000028726981,0.000012863783,0.000008416177,0.00003296739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028453258,0.00034435285,0.0008028888,0.0002412574,0.00013902984,0.00032720383,0.00036542068,0.000306944,0.0032401094],"category_scores_gemma":[0.00030844155,0.0001568453,0.00035237963,0.00018258236,0.00020451548,0.0002569822,0.00016315652,0.0007295666,0.00037502346],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.085331604,0.028835248,0.0035894841,0.0014633938,0.00047442073,0.00015087854,0.00012116564,0.0012806319,0.66560173,0.00021173764,0.0010118457,0.21192786],"study_design_scores_gemma":[0.07638132,0.5875842,0.09717696,0.00022159884,0.0013224123,0.0011252313,0.0002081258,0.0040360615,0.21899168,0.0002772035,0.012586202,0.00008901935],"about_ca_topic_score_codex":0.00024311114,"about_ca_topic_score_gemma":0.0005887033,"teacher_disagreement_score":0.0032401094,"about_ca_system_score_codex":0.00012221701,"about_ca_system_score_gemma":0.00019285188,"threshold_uncertainty_score":0.010839224},"labels":[],"label_agreement":null},{"id":"W2086591847","doi":"10.1080/09546630902984596","title":"Efalizumab discontinuation: A practical strategy","year":2009,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Efalizumab; Medicine; Discontinuation; Psoriasis; Plaque psoriasis; Dermatology; Progressive multifocal leukoencephalopathy; Monoclonal; Pharmacology; Monoclonal antibody; Immunology; Surgery; Multiple sclerosis; Antibody","score_opus":0.12147682256946304,"score_gpt":0.37707455563146003,"score_spread":0.25559773306199696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086591847","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014556196,0.96232754,0.0056171846,0.01908298,0.0030117186,0.00007749105,0.000056801196,0.00020964968,0.008161081],"genre_scores_gemma":[0.016737064,0.94378465,0.0062862947,0.013565679,0.00845251,0.00010386373,0.00019450673,0.000041482286,0.01083396],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995752,0.00010280663,0.00005730335,0.00007473573,0.00015324894,0.00003675103],"domain_scores_gemma":[0.9996182,0.00015531217,0.00008110716,0.000018497036,0.000073675015,0.000053138647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086264603,0.0013805756,0.0018412181,0.0015919541,0.00046227098,0.0010077822,0.0014200852,0.002290927,0.005266922],"category_scores_gemma":[0.001078918,0.00024575018,0.00074428716,0.0007881544,0.00057688495,0.0016692756,0.00055750215,0.0037426495,0.0033468937],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012931728,0.00013600849,0.00045905498,0.0031821125,0.00007944791,0.003418334,0.00006506917,0.00023347745,0.0014022066,0.003091745,0.085548826,0.90225446],"study_design_scores_gemma":[0.00019913833,0.00018625465,0.0019882838,0.0039960374,0.00014697397,0.019343348,0.00017212584,0.00030645734,0.0008511252,0.0073544616,0.9654107,0.000044948196],"about_ca_topic_score_codex":0.00056409265,"about_ca_topic_score_gemma":0.0011999907,"teacher_disagreement_score":0.005266922,"about_ca_system_score_codex":0.00056989404,"about_ca_system_score_gemma":0.0011497254,"threshold_uncertainty_score":0.01761967},"labels":[],"label_agreement":null},{"id":"W2103499669","doi":"10.3109/09546634.2012.713458","title":"Effect of adalimumab on sleep parameters in patients with psoriasis and obstructive sleep apnea: a randomized controlled trial","year":2012,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Adalimumab; Psoriasis; Polysomnography; Obstructive sleep apnea; Randomized controlled trial; Placebo; Sleep apnea; Internal medicine; Psoriasis Area and Severity Index; Anesthesia; Apnea; Dermatology; Tumor necrosis factor alpha","score_opus":0.009382823303474402,"score_gpt":0.2342899557498504,"score_spread":0.224907132446376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103499669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94546723,0.03407018,0.0009553036,0.0021934214,0.0025068398,0.008962637,0.00161731,0.00020568348,0.004021382],"genre_scores_gemma":[0.97339636,0.009598147,0.0016092868,0.0017672838,0.0012318247,0.00797481,0.0008617157,0.000022124981,0.0035384817],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986198,0.0007777847,0.0001473032,0.00020326,0.0001126675,0.00013930343],"domain_scores_gemma":[0.99838984,0.0006138849,0.0003841141,0.00010829813,0.00014171639,0.0003621254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025322565,0.0015286978,0.004708444,0.00054984173,0.0007117629,0.0014651874,0.00095398055,0.0026604293,0.008307973],"category_scores_gemma":[0.0029816949,0.0007888084,0.0029757072,0.00059873436,0.0010928931,0.00097027456,0.0004195305,0.0026807613,0.0008809805],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.987789,0.0018581466,0.00033021354,0.0013487277,0.0015997007,0.00002747973,0.00002102592,0.00007308477,0.00045995731,0.00004651003,0.00035820284,0.006087982],"study_design_scores_gemma":[0.98656285,0.011492303,0.00067530485,0.00005531677,0.00072682987,0.0000136312,0.000010099385,0.00011498194,0.000059490503,0.000046732766,0.00023669725,0.0000056291906],"about_ca_topic_score_codex":0.001355334,"about_ca_topic_score_gemma":0.0025136732,"teacher_disagreement_score":0.008307973,"about_ca_system_score_codex":0.0008098759,"about_ca_system_score_gemma":0.0012823201,"threshold_uncertainty_score":0.02779293},"labels":[],"label_agreement":null},{"id":"W2143292648","doi":"10.1080/09546630050517658","title":"Itraconazole pulse therapy is effective in dermatophyte onychomycosis of the toenail: a double-blind placebo-controlled study","year":2000,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; Rockyview General Hospital; Centre Hospitalier de l’Université de Montréal; University of Calgary; University of British Columbia; Hôtel-Dieu de Montréal; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Itraconazole; Medicine; Dermatophyte; Placebo; Adverse effect; Ketoconazole; Griseofulvin; Mycosis; Randomized controlled trial; Dermatology; Internal medicine; Surgery; Antifungal; Pathology","score_opus":0.034680874370046265,"score_gpt":0.3301356256944479,"score_spread":0.29545475132440163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143292648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98936814,0.0053040045,0.0006580936,0.00019075387,0.00033241615,0.0027289581,0.00040393567,0.000098915465,0.00091473525],"genre_scores_gemma":[0.98831135,0.0046418724,0.0015931713,0.00045498615,0.00096145185,0.0024773087,0.00048469665,0.00001694302,0.0010580572],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989794,0.00049832434,0.000112400216,0.00013083532,0.00018121066,0.00009780506],"domain_scores_gemma":[0.99827623,0.00062321546,0.00038373558,0.00016291381,0.00017737265,0.00037649868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020762468,0.0009784208,0.0028515593,0.0005623732,0.00050332956,0.00060584064,0.0010231677,0.0015795655,0.0044147614],"category_scores_gemma":[0.0024383375,0.0004920728,0.0010594219,0.0006208458,0.0012834112,0.00059493457,0.00021648605,0.001410198,0.00045539121],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.888161,0.03511619,0.0013160391,0.0023401428,0.0009070694,0.0001468542,0.00010314308,0.00015729168,0.019973647,0.00006523928,0.0006121831,0.05110132],"study_design_scores_gemma":[0.7542698,0.23549135,0.006960185,0.00007018788,0.0004758271,0.00011524273,0.00002476968,0.0002604929,0.0017132342,0.000034319313,0.0005697534,0.000014864776],"about_ca_topic_score_codex":0.0010480148,"about_ca_topic_score_gemma":0.0014070778,"teacher_disagreement_score":0.0044147614,"about_ca_system_score_codex":0.0003853159,"about_ca_system_score_gemma":0.0010206924,"threshold_uncertainty_score":0.014768839},"labels":[],"label_agreement":null},{"id":"W2331284076","doi":"10.3109/09546634.2014.952608","title":"Open-label exploratory study of acitretin for the treatment of severe chronic hand dermatitis","year":2014,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); Windsor Clinical Research","funders":"Actelion Pharmaceuticals","keywords":"Acitretin; Medicine; Psoriasis; Dermatology; Plaque psoriasis; Severity of illness; Internal medicine; Psoriasis Area and Severity Index","score_opus":0.0768447787380526,"score_gpt":0.3333239567455587,"score_spread":0.2564791780075061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331284076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98793054,0.00085884135,0.00062881113,0.00014786528,0.00011539649,0.008484329,0.00065077265,0.000040592477,0.0011428241],"genre_scores_gemma":[0.98402286,0.00081234926,0.0023056369,0.0004008119,0.0002600399,0.0094070975,0.0006260021,0.000010663811,0.00215441],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9985587,0.0007668596,0.000084246465,0.00022257629,0.00017327763,0.00019429118],"domain_scores_gemma":[0.9979157,0.0006603951,0.00035364975,0.00026544416,0.00018352216,0.00062126206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031615684,0.0012229163,0.002594379,0.0004429914,0.00078669307,0.00081059005,0.0008193409,0.0011630284,0.007832558],"category_scores_gemma":[0.0018427988,0.0005314271,0.0010956113,0.00046518532,0.0013699614,0.0007593188,0.0004773558,0.001992615,0.0009676459],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7600095,0.18251872,0.004396825,0.00081882544,0.00057781837,0.00026766237,0.00023411545,0.0005455677,0.01260298,0.00015385532,0.0007561567,0.037118006],"study_design_scores_gemma":[0.3190348,0.6708579,0.00756688,0.000027425709,0.00013691516,0.00011054743,0.000059710816,0.00031222444,0.0007915692,0.000074826174,0.0010104477,0.000016692427],"about_ca_topic_score_codex":0.00088314177,"about_ca_topic_score_gemma":0.0017792053,"teacher_disagreement_score":0.007832558,"about_ca_system_score_codex":0.0008422883,"about_ca_system_score_gemma":0.0023350103,"threshold_uncertainty_score":0.0262025},"labels":[],"label_agreement":null},{"id":"W2613579314","doi":"10.1080/09546634.2017.1329499","title":"What is clearance worth? Patients’ stated risk tolerance for psoriasis treatments","year":2017,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Duke University; Eli Lilly and Company","keywords":"Medicine; Psoriasis; Plaque psoriasis; Regimen; Dermatology; Logistic regression; Surgery; Internal medicine","score_opus":0.03240300307459103,"score_gpt":0.2863386960471726,"score_spread":0.25393569297258156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613579314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968374,0.0003702435,0.00043054146,0.000518521,0.000016644528,0.000018391602,0.000040016053,0.000004259969,0.0017639879],"genre_scores_gemma":[0.9996779,0.00004785472,0.000119703276,0.00007676521,0.000008321114,0.0000050009203,0.000011095894,6.790696e-7,0.00005263522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9922472,0.005098552,0.000646147,0.00037137937,0.0012581161,0.00037859133],"domain_scores_gemma":[0.9672568,0.018378006,0.010407501,0.0011664578,0.0012093124,0.0015818788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007160242,0.0002381708,0.00040742083,0.00049263577,0.0004509019,0.0017837274,0.00027622902,0.0008429648,0.00284867],"category_scores_gemma":[0.03818349,0.00016220813,0.00058421097,0.00030929552,0.0010870306,0.0010360166,0.0007447429,0.0011877392,0.0002064392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034894971,0.0014001523,0.8969548,0.00033700548,0.0006885212,0.00041346368,0.012658706,0.0018322684,0.0033768541,0.0016875971,0.0009595834,0.0762016],"study_design_scores_gemma":[0.00035365793,0.007981107,0.94048375,0.00034167877,0.00042364644,0.0024685771,0.028964136,0.006305058,0.0027862168,0.0043789223,0.0052863928,0.0002268941],"about_ca_topic_score_codex":0.00052688096,"about_ca_topic_score_gemma":0.00038000208,"teacher_disagreement_score":0.007160242,"about_ca_system_score_codex":0.0004846169,"about_ca_system_score_gemma":0.00038752286,"threshold_uncertainty_score":0.037867427},"labels":[],"label_agreement":null},{"id":"W2625462019","doi":"10.1080/09546634.2017.1343435","title":"Defining treatment success in rosacea as ‘clear’ may provide multiple patient benefits: results of a pooled analysis","year":2017,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Western University","funders":"Galderma","keywords":"Rosacea; Medicine; Dermatology Life Quality Index; Internal medicine; Randomized controlled trial; Quality of life (healthcare); Metronidazole; Clinical endpoint; Dermatology; Gastroenterology; Acne","score_opus":0.028051389488389117,"score_gpt":0.31710719955368644,"score_spread":0.28905581006529735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625462019","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2967102,0.6759362,0.010936082,0.0009838466,0.0017318036,0.0034752493,0.0070173685,0.0002690816,0.002940121],"genre_scores_gemma":[0.9442052,0.04186825,0.0048089013,0.0011618667,0.0011127337,0.0035350097,0.0022393784,0.00010792038,0.00096064445],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9457641,0.041573245,0.0055442345,0.0038586082,0.002490002,0.0007699632],"domain_scores_gemma":[0.94154155,0.042962667,0.009826757,0.0032384444,0.0018708641,0.0005597489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.043864872,0.0036049695,0.015913641,0.0026826283,0.00035473838,0.003364159,0.0014566496,0.0030804821,0.0046521723],"category_scores_gemma":[0.052409373,0.0012303694,0.047263786,0.0029977243,0.0010194645,0.0017045384,0.0018657241,0.001962598,0.0004726352],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11245196,0.00016718518,0.010122631,0.021487202,0.8442465,0.00011520621,0.0000726916,0.0007905071,0.00047755748,0.00009673859,0.00067013374,0.009301708],"study_design_scores_gemma":[0.030218992,0.0049504107,0.0187977,0.0012588017,0.9421258,0.00010101288,0.00007604359,0.00080477254,0.00024846953,0.000301202,0.0010535168,0.00006324005],"about_ca_topic_score_codex":0.0013202544,"about_ca_topic_score_gemma":0.001659575,"teacher_disagreement_score":0.043864872,"about_ca_system_score_codex":0.0010361169,"about_ca_system_score_gemma":0.0010572426,"threshold_uncertainty_score":0.23198241},"labels":[],"label_agreement":null},{"id":"W2760547991","doi":"10.1080/09546634.2017.1385719","title":"Optimal hidradenitis suppurativa topical treatment and wound care management: a revised algorithm","year":2017,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Wound care; Algorithm; Surgery; Pathology; Disease","score_opus":0.032124803347614174,"score_gpt":0.32221595158650507,"score_spread":0.2900911482388909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760547991","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0312152,0.23214309,0.28482604,0.32887903,0.016384434,0.013124176,0.0066646887,0.004178429,0.08258496],"genre_scores_gemma":[0.08014562,0.08670958,0.7821264,0.024718143,0.00566789,0.00433759,0.008149298,0.0003344007,0.0078110546],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99391717,0.0020870361,0.0013242068,0.000503018,0.0018613609,0.0003072486],"domain_scores_gemma":[0.9889775,0.0026152886,0.0013010777,0.00026138686,0.0057705767,0.0010741423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007993993,0.0028782592,0.003432237,0.0045107817,0.0017842199,0.0046312255,0.0043213507,0.003087949,0.005997873],"category_scores_gemma":[0.01673057,0.0010440811,0.0046979883,0.0021688154,0.0011725867,0.005032402,0.0037159706,0.0079765385,0.0034661419],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008447295,0.0011653238,0.025159786,0.004091479,0.000989942,0.0017535524,0.00036260832,0.0149123715,0.0008072651,0.012819095,0.32184094,0.6152529],"study_design_scores_gemma":[0.003263826,0.0030577295,0.05540949,0.033835698,0.004564258,0.026022615,0.002175797,0.09118095,0.0038030911,0.07187932,0.70396537,0.00084188144],"about_ca_topic_score_codex":0.00515655,"about_ca_topic_score_gemma":0.008953118,"teacher_disagreement_score":0.007993993,"about_ca_system_score_codex":0.0067533706,"about_ca_system_score_gemma":0.009416516,"threshold_uncertainty_score":0.04899937},"labels":[],"label_agreement":null},{"id":"W2892779110","doi":"10.1080/09546634.2018.1530439","title":"Pharmacokinetic disposition of topical phosphodiesterase-4 inhibitor E6005 in patients with atopic dermatitis","year":2018,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada","keywords":"Medicine; Atopic dermatitis; Pharmacokinetics; Adverse effect; Incidence (geometry); Drug; Dermatology; Logistic regression; Metabolite; Internal medicine; Clinical significance; Pharmacology","score_opus":0.011355264498628602,"score_gpt":0.27060175727833735,"score_spread":0.25924649277970874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892779110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988907,0.0005364094,0.00016418924,0.000019751802,0.0000025410563,0.000004716083,0.00007343803,0.0000032284977,0.00030506088],"genre_scores_gemma":[0.9996182,0.00010957464,0.00009952015,0.000018250912,0.0000044272,0.0000020298157,0.000060232585,6.043702e-7,0.00008705272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998467,0.000042018717,0.000017526536,0.00003703566,0.000038036054,0.000018731102],"domain_scores_gemma":[0.9996433,0.00012496719,0.00014670518,0.000018617242,0.00003161516,0.00003485198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025100485,0.00011947502,0.00023118485,0.00016415917,0.0001532295,0.0002290422,0.000060789913,0.00016821543,0.0009148525],"category_scores_gemma":[0.00085325993,0.00007890873,0.00017961666,0.00023624187,0.00007359899,0.00017571877,0.00009186967,0.00025592663,0.00012351936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001419812,0.00014876571,0.9788253,0.00004813117,0.00013466587,0.00048691372,0.00008252302,0.00024308216,0.004429892,0.00004186832,0.00015458671,0.01398444],"study_design_scores_gemma":[0.000049275277,0.0014025745,0.9932735,0.000008357266,0.00011560255,0.002208053,0.00008841672,0.0010088512,0.0011623988,0.000057745267,0.00061997824,0.0000052017845],"about_ca_topic_score_codex":0.00045674192,"about_ca_topic_score_gemma":0.00054799457,"teacher_disagreement_score":0.0009148525,"about_ca_system_score_codex":0.00013690587,"about_ca_system_score_gemma":0.00012121191,"threshold_uncertainty_score":0.00306046},"labels":[],"label_agreement":null},{"id":"W2904898191","doi":"10.1080/09546634.2018.1529386","title":"The journey for US psoriasis patients prescribed a topical: a retrospective database evaluation of patient progression to oral and/or biologic treatment","year":2018,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"LEO Pharma; Galderma; Sun Pharma; Mylan; Regeneron Pharmaceuticals; Celgene; Valeant Pharmaceuticals International; Sanofi; Eli Lilly and Company; Pfizer; National Psoriasis Foundation","keywords":"Medicine; Psoriasis; Retrospective cohort study; Biologic Agents; Topical agents; Internal medicine; Cohort; Observational study; Surgery; Dermatology; Disease","score_opus":0.0723164090166498,"score_gpt":0.34736504590440037,"score_spread":0.27504863688775055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904898191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922246,0.0009676233,0.00018321525,0.00017861246,0.000008944372,0.000059301445,0.0057828487,0.000008439916,0.0005863877],"genre_scores_gemma":[0.9957058,0.00047632967,0.0002449488,0.00013283895,0.00001227931,0.000066117485,0.0032614816,0.000004977592,0.00009530437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828255,0.00036921783,0.000403825,0.0004562859,0.00026836738,0.00021986783],"domain_scores_gemma":[0.99515766,0.0005683879,0.0032971248,0.0002754776,0.00032679687,0.00037450588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014481153,0.00021438103,0.00043615475,0.0012031737,0.0006704297,0.0011264274,0.0005118206,0.00041750458,0.0015484322],"category_scores_gemma":[0.004693797,0.00036031223,0.0008071739,0.0025076496,0.00022280413,0.00093423773,0.0008729238,0.0008573475,0.000270756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017781531,0.000039880466,0.9973775,0.000040332903,0.00009058665,0.00004478727,0.00012287797,0.000033588225,0.000053769945,0.00003056511,0.00046103616,0.0015272094],"study_design_scores_gemma":[0.00003948218,0.00013153549,0.9969926,0.00008550073,0.00013349707,0.00048391306,0.00069615594,0.000337214,0.00007951977,0.000041899337,0.000969463,0.000009255008],"about_ca_topic_score_codex":0.017162386,"about_ca_topic_score_gemma":0.019393165,"teacher_disagreement_score":0.017162386,"about_ca_system_score_codex":0.00097589893,"about_ca_system_score_gemma":0.0014881769,"threshold_uncertainty_score":0.03412497},"labels":[],"label_agreement":null},{"id":"W2919298825","doi":"10.1080/09546634.2019.1577346","title":"The Decoy Effect","year":2019,"lang":"en","type":"editorial","venue":"Journal of Dermatological Treatment","topic":"Mental Health and Psychiatry","field":"Arts and Humanities","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Biotech; LEO Pharma; Almirall; Galderma; Regeneron Pharmaceuticals; Sun Pharma; Mylan; National Psoriasis Foundation; Valeant Pharmaceuticals International; AbbVie; Celgene; Novartis; Pfizer","keywords":"Medicine; Psoriasis; Dermatology; Decoy; Pharmacology; Intensive care medicine; Internal medicine","score_opus":0.018810102207196273,"score_gpt":0.29655966380858917,"score_spread":0.2777495616013929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919298825","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000060984712,0.022793677,0.00011718665,0.0570305,0.91609263,0.000025172849,0.000081303915,0.000069992966,0.0037284384],"genre_scores_gemma":[0.00072487927,0.024148218,0.00018670081,0.09061066,0.85986674,0.000034666853,0.00005856526,0.000053264663,0.024316253],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997387,0.00056539016,0.00032416388,0.00035508952,0.0011805496,0.00018790335],"domain_scores_gemma":[0.99509877,0.002572334,0.00027960233,0.00015916499,0.0013776518,0.0005124603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037706313,0.0026889187,0.0021095905,0.0016205737,0.0018178471,0.005192779,0.002598187,0.010643172,0.013436736],"category_scores_gemma":[0.01090151,0.00069980917,0.0021752364,0.00072012015,0.0027211236,0.004590082,0.0016176207,0.02412771,0.010666365],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038308874,0.000010909795,0.000016400141,0.00029215493,0.000012699422,0.00007587725,0.000011770465,0.000010569326,0.00007499454,0.00075929513,0.98725253,0.011444423],"study_design_scores_gemma":[0.00006323395,0.000032087486,0.000108612796,0.0003183725,0.000025473502,0.00021046729,0.000023841529,0.000030294788,0.0001118422,0.0007376178,0.99832827,0.000009951945],"about_ca_topic_score_codex":0.001891203,"about_ca_topic_score_gemma":0.004615959,"teacher_disagreement_score":0.013436736,"about_ca_system_score_codex":0.0023314373,"about_ca_system_score_gemma":0.0025829854,"threshold_uncertainty_score":0.044950366},"labels":[],"label_agreement":null},{"id":"W2924267060","doi":"10.1080/09546634.2019.1587145","title":"Efficacy and safety of guselkumab, administered with a novel patient-controlled injector (One-Press), for moderate-to-severe psoriasis: results from the phase 3 ORION study","year":2019,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"Janssen Research and Development; Eli Lilly and Company","keywords":"Medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Adverse effect; Dosing; Interim analysis; Internal medicine; Randomized controlled trial; Dermatology; Surgery","score_opus":0.04277174648646291,"score_gpt":0.2797984276950329,"score_spread":0.23702668120856996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924267060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581534,0.0019583122,0.0004769574,0.00013183401,0.000028877079,0.00059986964,0.00029746705,0.000038443533,0.0006529208],"genre_scores_gemma":[0.99585503,0.0010322463,0.0009550419,0.00038551007,0.000076308104,0.0004981461,0.0005057614,0.000018553783,0.00067334506],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986646,0.0008225738,0.00007540011,0.00012654654,0.00021359076,0.00009727823],"domain_scores_gemma":[0.9987864,0.00030677998,0.00048075014,0.000103347906,0.0000972323,0.00022548987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034912657,0.0006387682,0.0009839085,0.00020098423,0.00026493156,0.0006105586,0.00049475033,0.00078358134,0.0024741737],"category_scores_gemma":[0.001387553,0.0002965678,0.0011754447,0.00022556276,0.00062081387,0.00074345595,0.00020284302,0.0018064271,0.00042252298],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6597242,0.06539853,0.014065596,0.0017210613,0.0022849943,0.00013777775,0.0005956613,0.00085363357,0.09469021,0.00023962115,0.0026352082,0.15765357],"study_design_scores_gemma":[0.32330224,0.6013467,0.060969934,0.000092606955,0.0012511833,0.00050052605,0.00010458655,0.0010725551,0.0085535655,0.00014136046,0.002616405,0.000048440852],"about_ca_topic_score_codex":0.0003595179,"about_ca_topic_score_gemma":0.0008099068,"teacher_disagreement_score":0.0034912657,"about_ca_system_score_codex":0.0004420113,"about_ca_system_score_gemma":0.0007464219,"threshold_uncertainty_score":0.01846379},"labels":[],"label_agreement":null},{"id":"W2924550304","doi":"10.1080/09546634.2019.1587144","title":"Real-world use of extracorporeal photopheresis for patients with cutaneous T-cell lymphoma in the United States: 2010–2015","year":2019,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Extracorporeal Photopheresis; Photopheresis; Cutaneous T-cell lymphoma; Dermatology; Lymphoma; Extracorporeal; Surgery; Mycosis fungoides; Internal medicine; Disease; Graft-versus-host disease","score_opus":0.042319942350103674,"score_gpt":0.3111525509298505,"score_spread":0.26883260857974683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924550304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98892504,0.00240364,0.0001965945,0.000518931,0.000021251712,0.000017468632,0.0070133437,0.000018217137,0.00088551344],"genre_scores_gemma":[0.9956476,0.00072822144,0.000121703764,0.0001889623,0.000024635025,0.000013695251,0.0031817008,0.0000035372664,0.0000898133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989491,0.0002653372,0.00021939883,0.00025988295,0.00021177295,0.000094660514],"domain_scores_gemma":[0.9963367,0.0005235372,0.0025094617,0.00010849583,0.0002366449,0.00028527732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007648148,0.0001420804,0.00022862175,0.00063604786,0.0001988994,0.0006753648,0.0003673333,0.00030903585,0.001073199],"category_scores_gemma":[0.0031272855,0.00015209842,0.00046013325,0.0014538371,0.00024157,0.000534752,0.00047194617,0.0005122425,0.00016439539],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010151147,0.000034640885,0.9938426,0.000043959102,0.00012064641,0.000055692326,0.00004785482,0.00020967654,0.00008189959,0.000038082635,0.001250187,0.00417332],"study_design_scores_gemma":[0.000012253733,0.000043573087,0.9976331,0.000034116016,0.000051351584,0.0003250135,0.00015602575,0.000559604,0.000099374534,0.000026748412,0.0010523932,0.000006436397],"about_ca_topic_score_codex":0.016504785,"about_ca_topic_score_gemma":0.021104107,"teacher_disagreement_score":0.016504785,"about_ca_system_score_codex":0.0012579839,"about_ca_system_score_gemma":0.0007316836,"threshold_uncertainty_score":0.032817423},"labels":[],"label_agreement":null},{"id":"W2943808099","doi":"10.1080/09546634.2019.1603361","title":"US real-world effectiveness of secukinumab for the treatment of psoriasis: 6-month analysis from the Corrona Psoriasis Registry","year":2019,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Secukinumab; Medicine; Psoriasis; Quality of life (healthcare); Clinical endpoint; Internal medicine; Dermatology; Physical therapy; Psoriatic arthritis; Clinical trial","score_opus":0.023680204545905303,"score_gpt":0.27491816307371164,"score_spread":0.25123795852780634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943808099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98996836,0.0028735655,0.00027128062,0.00020465368,0.000021367056,0.00009409397,0.0052922894,0.000020609119,0.0012536348],"genre_scores_gemma":[0.99506915,0.0005497591,0.0002563194,0.00009449954,0.00003783897,0.00007906862,0.0037901595,0.00000888131,0.00011418405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9892565,0.006461219,0.0012205944,0.00096849306,0.0017707269,0.00032255144],"domain_scores_gemma":[0.9753102,0.0058314255,0.015299339,0.0016655809,0.0012991986,0.00059428316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008795996,0.00025223507,0.0008275483,0.0008813899,0.00032640374,0.0009494803,0.00052443513,0.00051080127,0.0013172188],"category_scores_gemma":[0.017659396,0.00020417178,0.0014248963,0.0019038672,0.00033522738,0.0007908567,0.00076941686,0.00066788075,0.00032972777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066463095,0.00043322786,0.9728684,0.00029256844,0.0022800493,0.00009404548,0.000117309566,0.00093551434,0.00032043093,0.00006474596,0.0014975339,0.014449746],"study_design_scores_gemma":[0.00042143452,0.0017102952,0.9935296,0.00006451457,0.00082138414,0.00041690023,0.00013187042,0.0007433769,0.00023720675,0.000025437614,0.0018743976,0.000023659912],"about_ca_topic_score_codex":0.001968625,"about_ca_topic_score_gemma":0.0029143128,"teacher_disagreement_score":0.008795996,"about_ca_system_score_codex":0.0005939213,"about_ca_system_score_gemma":0.00060682715,"threshold_uncertainty_score":0.046518207},"labels":[],"label_agreement":null},{"id":"W2946162325","doi":"10.1080/09546634.2019.1623368","title":"Characterizing high-burden rosacea subjects: a multivariate risk factor analysis from a global survey","year":2019,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Windsor Clinical Research; Western University","funders":"","keywords":"Rosacea; Medicine; Multivariate analysis; Multivariate statistics; Logistic regression; Risk factor; Quality of life (healthcare); Protective factor; Demography; Gerontology; Internal medicine; Dermatology","score_opus":0.02654028591772164,"score_gpt":0.29776543186369037,"score_spread":0.27122514594596875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946162325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99922574,0.000078244986,0.00020026015,0.00003519688,0.0000023438006,0.0000131797615,0.00029471365,0.000003892365,0.00014637926],"genre_scores_gemma":[0.9994929,0.000028781682,0.000103813305,0.00001023289,0.0000042093297,0.000008387522,0.00031072303,0.0000015098107,0.00003945257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992035,0.00038571339,0.000060969785,0.00010927335,0.00012526532,0.00011525376],"domain_scores_gemma":[0.9984975,0.00035621217,0.0006226983,0.00016052033,0.00011600126,0.00024703593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001468505,0.00041101154,0.00043069397,0.0008791538,0.00027600495,0.00047736787,0.00022862175,0.0003448149,0.0015934623],"category_scores_gemma":[0.0027896585,0.00021764525,0.000863791,0.0010380993,0.00021082534,0.0004114941,0.00073108316,0.0004711582,0.00022746892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006309449,0.00001944425,0.99897194,0.0000048664338,0.00004604348,0.000017185415,0.000025444508,0.000031795902,0.00006566867,0.0000045509987,0.00004983114,0.00070013426],"study_design_scores_gemma":[0.000005962281,0.00007666655,0.9992151,0.0000027417352,0.000026152033,0.000073000454,0.00011899661,0.00039151992,0.00001728107,0.0000092133005,0.00006129266,0.0000019811096],"about_ca_topic_score_codex":0.003062012,"about_ca_topic_score_gemma":0.00215784,"teacher_disagreement_score":0.003062012,"about_ca_system_score_codex":0.00014794579,"about_ca_system_score_gemma":0.0002241247,"threshold_uncertainty_score":0.0077663064},"labels":[],"label_agreement":null},{"id":"W2947828030","doi":"10.1080/09546634.2019.1620502","title":"Review of international psoriasis guidelines for the treatment of psoriasis: recommendations for topical corticosteroid treatments","year":2019,"lang":"en","type":"editorial","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"LEO Pharma; National Institute for Health and Care Research","keywords":"Medicine; Psoriasis; Plaque psoriasis; Dermatology; Corticosteroid; Population; Disease; Intensive care medicine; Surgery; Internal medicine; Environmental health","score_opus":0.10088429690659054,"score_gpt":0.3779725897040562,"score_spread":0.2770882927974657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947828030","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019011676,0.6790075,0.0012072087,0.055921126,0.25095695,0.00021499315,0.0005657963,0.00022142357,0.0117149325],"genre_scores_gemma":[0.0013126483,0.77143157,0.0021727239,0.035780948,0.17527138,0.00016716031,0.0009261393,0.0001004881,0.012836821],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972013,0.00069538166,0.0006168914,0.00015588179,0.0012065864,0.00012397545],"domain_scores_gemma":[0.98969156,0.002950691,0.00114603,0.00014400252,0.0054038563,0.0006637808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003393518,0.0013966424,0.0027684818,0.005309344,0.00065332005,0.002196811,0.0019841818,0.0031828783,0.012799999],"category_scores_gemma":[0.010152052,0.00052134227,0.0017895637,0.002972444,0.00067897816,0.0017952321,0.0008260368,0.0052066604,0.010908263],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042397165,0.00003110579,0.000038897888,0.002738658,0.000035192323,0.000074413176,0.000014315739,0.00004437193,0.00011778686,0.00024061218,0.9066156,0.09000664],"study_design_scores_gemma":[0.000042374668,0.000032513097,0.00033412495,0.005686005,0.00012810499,0.0003824111,0.000021977758,0.000046235684,0.000059836217,0.0003965806,0.9928536,0.000016204083],"about_ca_topic_score_codex":0.0021674763,"about_ca_topic_score_gemma":0.005348545,"teacher_disagreement_score":0.012799999,"about_ca_system_score_codex":0.0015538046,"about_ca_system_score_gemma":0.003911729,"threshold_uncertainty_score":0.042820275},"labels":[],"label_agreement":null},{"id":"W2978693937","doi":"10.1080/09546634.2019.1656797","title":"Characterization of insufficient responders to anti-tumor necrosis factor therapies in patients with moderate to severe psoriasis: real-world data from the US Corrona Psoriasis Registry","year":2019,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Psoriasis; Demographics; Internal medicine; Logistic regression; Tumor necrosis factor alpha; Body surface area; Dermatology; Physical therapy; Demography","score_opus":0.034188831077173486,"score_gpt":0.2590051900631193,"score_spread":0.2248163589859458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978693937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941478,0.0006466202,0.0002898673,0.00012418209,0.0000071124955,0.000045830748,0.0037269979,0.0000097637,0.0010019332],"genre_scores_gemma":[0.99729866,0.00015443398,0.00020176996,0.000058858906,0.00001295951,0.000041755688,0.0021288912,0.0000034435272,0.000099302575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962508,0.0017341422,0.0006762175,0.0005437902,0.0005951741,0.00019994462],"domain_scores_gemma":[0.98760974,0.002406088,0.0077488758,0.00093908486,0.0009031508,0.00039311431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031718097,0.00013636309,0.00042160807,0.0009334707,0.00029900623,0.00067177194,0.0004115402,0.00030453084,0.0012546936],"category_scores_gemma":[0.007715861,0.00015004829,0.0004038425,0.0012847332,0.00022750058,0.00044673527,0.0006310882,0.000395545,0.00030980812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014785543,0.000020986545,0.9980501,0.00001929781,0.000035524205,0.000024494491,0.00003811831,0.000037947,0.000072935654,0.000019538325,0.0002693545,0.0012639227],"study_design_scores_gemma":[0.000019905397,0.00008203427,0.9983291,0.000019656312,0.000032487336,0.00027501673,0.00020661663,0.00021380243,0.00009182978,0.000023052422,0.0007015338,0.0000049695054],"about_ca_topic_score_codex":0.003005063,"about_ca_topic_score_gemma":0.0038653256,"teacher_disagreement_score":0.0031718097,"about_ca_system_score_codex":0.00027196162,"about_ca_system_score_gemma":0.00039670014,"threshold_uncertainty_score":0.016774356},"labels":[],"label_agreement":null},{"id":"W2979619560","doi":"10.1080/09546634.2019.1675854","title":"The potential role of cannabinoids in dermatology","year":2019,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Acne; Atopic dermatitis; Psoriasis; Dermatology; Cannabis; Antipruritic; Synthetic cannabinoids; Skin cancer; Cannabinoid; Cancer; Psychiatry","score_opus":0.04341714290984188,"score_gpt":0.3689631632026301,"score_spread":0.32554602029278823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979619560","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009489737,0.99880946,0.000035086654,0.00018829036,0.00012587143,0.0000012391109,0.00000427564,0.0000024552373,0.00073850976],"genre_scores_gemma":[0.0011335105,0.9980209,0.00007231344,0.00014700273,0.00019001483,0.0000017190475,0.0000076251113,5.2362833e-7,0.00042646384],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999813,0.000033877768,0.00002657449,0.000029759149,0.00007845405,0.000018373323],"domain_scores_gemma":[0.99974185,0.00013185872,0.00003216628,0.000007543449,0.00006341009,0.000023206314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038530325,0.00048194206,0.00084725244,0.0024798387,0.00039749357,0.0010453919,0.00052631675,0.0009963242,0.003615041],"category_scores_gemma":[0.0005650074,0.00016583025,0.00042973415,0.0018960238,0.000507135,0.0010720285,0.00067230925,0.0014202333,0.0010166987],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006304745,0.00008013615,0.0003289059,0.01765516,0.000077999095,0.0005410883,0.00011634317,0.00023031907,0.0019371705,0.0067100287,0.019836549,0.9524233],"study_design_scores_gemma":[0.00001793295,0.00007356087,0.0017210635,0.0057697636,0.0001151907,0.0043939236,0.0001581492,0.00009098171,0.00049591524,0.0053092097,0.9818304,0.000023831208],"about_ca_topic_score_codex":0.0017094918,"about_ca_topic_score_gemma":0.0030257874,"teacher_disagreement_score":0.003615041,"about_ca_system_score_codex":0.0006362288,"about_ca_system_score_gemma":0.001225749,"threshold_uncertainty_score":0.012093544},"labels":[],"label_agreement":null},{"id":"W2980410436","doi":"10.1080/09546634.2019.1679336","title":"Consistent response to guselkumab treatment between Hispanic and non-Hispanic patients with psoriasis: an analysis from VOYAGE 1 and VOYAGE 2","year":2019,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Queen's University","funders":"","keywords":"Medicine; Dermatology Life Quality Index; Adalimumab; Psoriasis; Internal medicine; Placebo; Psoriasis Area and Severity Index; Population; Dermatology; Adverse effect; Confidence interval; Gastroenterology; Disease; Pathology","score_opus":0.014621732709655786,"score_gpt":0.23792431000547995,"score_spread":0.22330257729582417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980410436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985065,0.0006051648,0.00008867916,0.000031521315,0.000016665737,0.000053219956,0.0004463723,0.0000036810895,0.00024821825],"genre_scores_gemma":[0.9984762,0.00011948769,0.00007391129,0.00010415046,0.000024732686,0.000056100733,0.00093653036,0.00000623838,0.00020258756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984549,0.000719642,0.00013808759,0.00031454122,0.00019751406,0.00017530964],"domain_scores_gemma":[0.9976889,0.00071741507,0.00066275423,0.00028835263,0.00016776848,0.00047489695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023134165,0.00042125213,0.0010652889,0.0004718843,0.0004357327,0.0008034628,0.00045238074,0.0006179005,0.0029663665],"category_scores_gemma":[0.0021086643,0.00031367145,0.0021552478,0.0005430044,0.00041475752,0.00042214736,0.0005566576,0.00089347374,0.00032039144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14663383,0.002093927,0.8246403,0.00025449658,0.007715586,0.0002119422,0.0004230345,0.0002777845,0.004271059,0.00009443335,0.0009388859,0.012444703],"study_design_scores_gemma":[0.008575933,0.00879563,0.97806394,0.000034032768,0.0014794436,0.00033138375,0.0003773236,0.00050351734,0.00043974168,0.00007972955,0.0012870887,0.00003224497],"about_ca_topic_score_codex":0.0014092877,"about_ca_topic_score_gemma":0.001544174,"teacher_disagreement_score":0.0029663665,"about_ca_system_score_codex":0.0005113476,"about_ca_system_score_gemma":0.0005277316,"threshold_uncertainty_score":0.012234688},"labels":[],"label_agreement":null},{"id":"W2981124378","doi":"10.1080/09546634.2019.1682501","title":"Adverse reactions associated with the esthetic use of soft tissue fillers and neurotoxins: a 53-year retrospective analysis of MedEffect™, Health Canada’s reporting database","year":2019,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Facial Rejuvenation and Surgery Techniques","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; GDI Integrated Facility Services (Canada); Victoria Park; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"","keywords":"Medicine; Soft tissue; Adverse effect; Database; Drug reaction; Brain tissue; Surgery; Internal medicine; Psychiatry; Drug","score_opus":0.04077285448652362,"score_gpt":0.30804392235239136,"score_spread":0.26727106786586774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981124378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96784896,0.006464367,0.000477148,0.00024069671,0.000026437872,0.00042087724,0.021382611,0.00004856926,0.0030904745],"genre_scores_gemma":[0.9858677,0.0032841933,0.00038431425,0.0003353492,0.00003000908,0.00012523713,0.00942913,0.000016151826,0.0005280243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9920696,0.000625773,0.0016149421,0.00071990455,0.004248083,0.00072181155],"domain_scores_gemma":[0.96726334,0.0031882296,0.016926892,0.0012078764,0.010325333,0.0010882292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031144754,0.00038583198,0.00056518195,0.0057375105,0.0011406579,0.0014646184,0.0007977358,0.00030837776,0.0010826678],"category_scores_gemma":[0.010486063,0.0004384381,0.0007179378,0.008837146,0.0006789264,0.00053951173,0.00087242323,0.00048801015,0.00023218064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008301049,0.000013452137,0.9956417,0.00008723942,0.00007631068,0.00011874091,0.00016412268,0.000023174418,0.00006186667,0.000014390161,0.00070178,0.0030140872],"study_design_scores_gemma":[0.000005752867,0.000034466713,0.9979279,0.0000674707,0.00006569583,0.0003296481,0.00036149716,0.00009045616,0.00010757518,0.000004666978,0.0009960039,0.000008887437],"about_ca_topic_score_codex":0.6983164,"about_ca_topic_score_gemma":0.62777996,"teacher_disagreement_score":0.3016836,"about_ca_system_score_codex":0.008547175,"about_ca_system_score_gemma":0.010731907,"threshold_uncertainty_score":0.60692054},"labels":[],"label_agreement":null},{"id":"W2987717944","doi":"10.1080/09546634.2019.1687821","title":"Fractional CO<sub>2</sub> laser is as effective as pulsed dye laser for the treatment of hypertrophic scars","year":2019,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Scars; Hypertrophic scars; Dye laser; Laser; Hypertrophic scar; Surgery; Pulse (music); Optics","score_opus":0.026417809179209842,"score_gpt":0.3358724853790428,"score_spread":0.30945467619983297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987717944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98569727,0.010847462,0.0010293066,0.000104163795,0.00002769014,0.00002241956,0.000019404197,0.00003446248,0.0022177922],"genre_scores_gemma":[0.99809915,0.00091616524,0.0005628801,0.00005764364,0.000027455862,0.000012126595,0.000025756755,0.000004954667,0.00029386888],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997609,0.000058640435,0.000012800963,0.000028067274,0.00009785768,0.00004172542],"domain_scores_gemma":[0.99972886,0.00012535845,0.000058478334,0.000015669006,0.000025050487,0.000046555455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038426826,0.00015418361,0.00032168883,0.00030064816,0.00018899178,0.00023942626,0.0001927651,0.0002463317,0.0016241489],"category_scores_gemma":[0.000555603,0.000080441314,0.00019694658,0.00017542481,0.00038675262,0.00022908347,0.00013142709,0.00017454865,0.00014572174],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020814063,0.0022387253,0.0541347,0.0009539805,0.0002901472,0.0017269584,0.00028833357,0.00090025354,0.4133319,0.00033818334,0.0011855467,0.5037971],"study_design_scores_gemma":[0.004013774,0.0976793,0.63281757,0.0003359061,0.001105986,0.033960152,0.0015112892,0.0072669876,0.20239744,0.00073351664,0.01804648,0.00013154818],"about_ca_topic_score_codex":0.0007804348,"about_ca_topic_score_gemma":0.001321921,"teacher_disagreement_score":0.0016241489,"about_ca_system_score_codex":0.0002091691,"about_ca_system_score_gemma":0.00021140104,"threshold_uncertainty_score":0.0054332614},"labels":[],"label_agreement":null},{"id":"W2991340463","doi":"10.1080/09546634.2019.1688755","title":"Meta-analysis of photobiomodulation for the treatment of androgenetic alopecia","year":2019,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mediprobe Research (Canada)","funders":"","keywords":"Medicine; Meta-analysis; Subgroup analysis; Adverse effect; Intense pulsed light; Significant difference; Treatment effect; Dermatology; Safety profile; Internal medicine; Surgery; Traditional medicine","score_opus":0.4128497960390892,"score_gpt":0.43823159720045823,"score_spread":0.02538180116136901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991340463","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009588589,0.9883549,0.00049893296,0.00025480005,0.00023715662,0.00015509002,0.00037779877,0.000030075149,0.0005026814],"genre_scores_gemma":[0.41953012,0.5734751,0.0027274778,0.0014390093,0.0005261456,0.00069671735,0.0008693769,0.00004864314,0.0006873951],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9932714,0.0041379416,0.0010864239,0.00071684114,0.0005894638,0.00019795667],"domain_scores_gemma":[0.98857456,0.00878216,0.0015140268,0.00037023437,0.00058587716,0.000173198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009259344,0.0021459647,0.012165779,0.0031314446,0.00054816954,0.0025907613,0.001334075,0.002004716,0.0037984631],"category_scores_gemma":[0.0190475,0.000768219,0.030840075,0.0032053129,0.0005526635,0.0010420469,0.0008356996,0.0018846483,0.0002622583],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008905425,0.00006655082,0.0033353872,0.14553459,0.821732,0.00012108881,0.00004758945,0.00088664214,0.0005065023,0.00017436224,0.0008937765,0.0177961],"study_design_scores_gemma":[0.0020266566,0.0006221633,0.0048234323,0.008210449,0.9814016,0.00010072237,0.000023869397,0.00028162936,0.00022136183,0.00029067008,0.0019812088,0.0000162066],"about_ca_topic_score_codex":0.00427815,"about_ca_topic_score_gemma":0.006863665,"teacher_disagreement_score":0.012165779,"about_ca_system_score_codex":0.0016517446,"about_ca_system_score_gemma":0.0012886794,"threshold_uncertainty_score":0.048968673},"labels":[],"label_agreement":null},{"id":"W3003638259","doi":"10.1080/09546634.2020.1724250","title":"Topical treatment of psoriasis: questionnaire results on topical therapy as long-term continuous treatment and use on specific body sites","year":2020,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Innovaderm (Canada)","funders":"Cilag; LEO Pharma; Bausch Health; Bristol-Myers Squibb; Eli Lilly and Company; Galderma; Sanofi Genzyme; Incyte; Dermira; Regeneron Pharmaceuticals; Celgene; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer","keywords":"Medicine; Psoriasis; Dermatology; Term (time)","score_opus":0.061345816132115996,"score_gpt":0.2869051222724769,"score_spread":0.2255593061403609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003638259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690616,0.003133842,0.001949475,0.0015612819,0.00012359451,0.00072898204,0.0070705446,0.00010366611,0.016266951],"genre_scores_gemma":[0.989778,0.0017376749,0.0032566248,0.00063159945,0.000072216724,0.0004180981,0.0022148723,0.000026430533,0.0018645412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99699235,0.0010955766,0.0006506496,0.00017687847,0.0008353375,0.00024914005],"domain_scores_gemma":[0.98825306,0.0034980867,0.0053839376,0.00033629016,0.001731809,0.00079678214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030985593,0.00020210998,0.00029862847,0.0010448492,0.00022920515,0.00046791552,0.00026585488,0.00046266662,0.005418249],"category_scores_gemma":[0.006733186,0.00009985373,0.00060141593,0.00093504495,0.00024413178,0.0005966827,0.0005712261,0.00057945703,0.0011209885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039346798,0.00040751635,0.9300181,0.000748195,0.00020653353,0.00014322335,0.0014371626,0.00036170476,0.0025061932,0.00018583878,0.010622749,0.052969445],"study_design_scores_gemma":[0.00004009439,0.0006664413,0.9796377,0.0002645228,0.000059032813,0.0009408983,0.001963319,0.0003122252,0.0005104284,0.00009350351,0.0154835265,0.000028317338],"about_ca_topic_score_codex":0.00070942397,"about_ca_topic_score_gemma":0.0008106352,"teacher_disagreement_score":0.005418249,"about_ca_system_score_codex":0.00040067697,"about_ca_system_score_gemma":0.0003791009,"threshold_uncertainty_score":0.018125832},"labels":[],"label_agreement":null},{"id":"W3004935569","doi":"10.1080/09546634.2020.1720586","title":"Characterization of insufficient responders to ustekinumab in patients with moderate-to-severe psoriasis in the US Corrona Psoriasis Registry","year":2020,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Ustekinumab; Medicine; Psoriasis; Plaque psoriasis; Logistic regression; Internal medicine; Demographics; Dermatology; Disease; Adalimumab; Demography","score_opus":0.022571259567142524,"score_gpt":0.23226676470145394,"score_spread":0.2096955051343114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004935569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668545,0.00041075607,0.00025732748,0.000111641966,0.000009204422,0.0000471183,0.0013658444,0.000012267268,0.0011004927],"genre_scores_gemma":[0.9980672,0.00011934481,0.00022007023,0.00006970402,0.000017961702,0.000038869937,0.0013129414,0.000006793706,0.00014703999],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966425,0.0013878539,0.00065894984,0.00046773045,0.0006015933,0.00024134447],"domain_scores_gemma":[0.98880273,0.002211925,0.0065569184,0.00094949757,0.0009525086,0.0005263617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038830047,0.00016706996,0.00054777367,0.0012623732,0.0003850207,0.0008417439,0.0006229363,0.00032803087,0.001700703],"category_scores_gemma":[0.009139756,0.00017196823,0.0005294048,0.0012561495,0.00023349111,0.0006471219,0.000888697,0.00049974484,0.00044925936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020415137,0.000026417574,0.9977157,0.000015564488,0.000031928583,0.000047100213,0.000052931347,0.000039838214,0.00010789574,0.000026874155,0.00027242553,0.0014591118],"study_design_scores_gemma":[0.000024357321,0.00013466133,0.99719906,0.000028262455,0.000058805843,0.0005723415,0.0003562825,0.00044330137,0.00021003705,0.000044337787,0.0009199317,0.000008685369],"about_ca_topic_score_codex":0.0021927413,"about_ca_topic_score_gemma":0.0030953265,"teacher_disagreement_score":0.0038830047,"about_ca_system_score_codex":0.00023464982,"about_ca_system_score_gemma":0.0004947471,"threshold_uncertainty_score":0.020535529},"labels":[],"label_agreement":null},{"id":"W3007535309","doi":"10.1080/09546634.2020.1729335","title":"Long-term topical management of psoriasis: the road ahead","year":2020,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"LEO Pharma Research Foundation","keywords":"Medicine; Psoriasis; Context (archaeology); Terminology; Intensive care medicine; Expert opinion; Dermatology","score_opus":0.050516262711469605,"score_gpt":0.31762364054293424,"score_spread":0.26710737783146465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007535309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00064419885,0.74259543,0.0016855266,0.24068168,0.010097707,0.000033666354,0.000053182153,0.000039176382,0.0041695167],"genre_scores_gemma":[0.013303456,0.8440405,0.0076731117,0.10634233,0.024836559,0.00008601468,0.000106642874,0.0000632479,0.00354814],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99269694,0.0033314056,0.0011476543,0.00047098665,0.0019763426,0.0003766237],"domain_scores_gemma":[0.9686386,0.019712482,0.002341873,0.00066305493,0.0071628545,0.0014811251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011326461,0.00048796434,0.0015427567,0.00089549617,0.0012839162,0.0051883003,0.0014699796,0.0076520555,0.0071713524],"category_scores_gemma":[0.01983132,0.00035024286,0.0015133972,0.00085622247,0.0028194916,0.012543102,0.0023778444,0.013221913,0.003130376],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002674117,0.00020164631,0.0009846956,0.015702901,0.00011969523,0.0007753563,0.00154938,0.00021228884,0.0013030338,0.024074277,0.18488663,0.7699226],"study_design_scores_gemma":[0.000033163695,0.00021141562,0.0012444069,0.021129915,0.00012814377,0.0021059464,0.0021799714,0.00014167916,0.0003131047,0.02023222,0.9522029,0.00007712364],"about_ca_topic_score_codex":0.0024560322,"about_ca_topic_score_gemma":0.007940394,"teacher_disagreement_score":0.011326461,"about_ca_system_score_codex":0.0020384756,"about_ca_system_score_gemma":0.0067283823,"threshold_uncertainty_score":0.05990076},"labels":[],"label_agreement":null},{"id":"W3014639863","doi":"10.1080/09546634.2020.1749547","title":"Efficacy of non-surgical treatments for androgenetic alopecia in men and women: a systematic review with network meta-analyses, and an assessment of evidence quality","year":2020,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mediprobe Research (Canada)","funders":"","keywords":"Medicine; Minoxidil; Randomized controlled trial; Bimatoprost; Finasteride; Meta-analysis; Randomization; Quality of evidence; Internal medicine; Urology; Surgery; Latanoprost","score_opus":0.41185573417425464,"score_gpt":0.5435135726847296,"score_spread":0.1316578385104749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014639863","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003488214,0.99291927,0.0012821663,0.0003101974,0.00013161644,0.00074051594,0.00077636604,0.000029092493,0.00032266442],"genre_scores_gemma":[0.19978741,0.78563106,0.007302595,0.001093981,0.0003357632,0.0038894522,0.0015913214,0.000045277353,0.00032314428],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9745077,0.014549304,0.0062808297,0.0019366288,0.0023477098,0.00037784784],"domain_scores_gemma":[0.94020504,0.04775935,0.008025695,0.0012395588,0.0023751946,0.0003951749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030749312,0.003448861,0.019518742,0.014938592,0.00073383824,0.003949841,0.0024246513,0.0022783417,0.0039555086],"category_scores_gemma":[0.07509498,0.0016001482,0.039852805,0.010532073,0.0009829422,0.0026034627,0.0023959943,0.0016749605,0.00027849947],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012766601,0.000032361182,0.003096491,0.45084864,0.527988,0.000082641905,0.00008568038,0.00077053613,0.000131717,0.00022282501,0.00042086217,0.015043595],"study_design_scores_gemma":[0.0005358141,0.00018474403,0.00228643,0.039280925,0.95506454,0.000078767756,0.000044345037,0.00037379892,0.00006754335,0.00042080902,0.0016401353,0.00002219781],"about_ca_topic_score_codex":0.0057294536,"about_ca_topic_score_gemma":0.012127995,"teacher_disagreement_score":0.030749312,"about_ca_system_score_codex":0.0037738157,"about_ca_system_score_gemma":0.0050371243,"threshold_uncertainty_score":0.16261983},"labels":[],"label_agreement":null},{"id":"W3021421518","doi":"10.1080/09546634.2020.1747590","title":"Disease activity and treatment efficacy using patient-level Psoriasis Area and Severity Index scores from tildrakizumab phase 3 clinical trials","year":2020,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Université Laval; Centre de Recherche Dermatologique du Québec Métropolitain; Hôtel-Dieu de Québec","funders":"Merck Sharp and Dohme","keywords":"Medicine; Psoriasis Area and Severity Index; Psoriasis; Internal medicine; Dermatology Life Quality Index; Clinical trial; Placebo; Severity of illness; Plaque psoriasis; Gastroenterology; Quality of life (healthcare); Dermatology; Physical therapy; Pathology","score_opus":0.26164119865088536,"score_gpt":0.3907763029369532,"score_spread":0.12913510428606784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021421518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86346376,0.069079496,0.016059611,0.002764466,0.0005334482,0.005248181,0.019102858,0.0002712474,0.02347708],"genre_scores_gemma":[0.9874813,0.0019174942,0.0042774715,0.0005426253,0.00014355232,0.0017521918,0.0032368905,0.000031866053,0.0006167677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9356927,0.045679092,0.0074989307,0.0028445905,0.0077212974,0.00056337315],"domain_scores_gemma":[0.9213142,0.041977093,0.027395263,0.0029264041,0.0052413354,0.0011456637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06406603,0.0007739883,0.0016897845,0.001533552,0.00039575962,0.0019774693,0.00097164646,0.00084852293,0.0041977745],"category_scores_gemma":[0.06260165,0.00025943737,0.0026579697,0.0020466608,0.00069646194,0.0016097035,0.00091197394,0.0018798045,0.0007183974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09906929,0.0017235918,0.68017566,0.008781797,0.02883688,0.00010022285,0.0005868909,0.004170353,0.0036840441,0.0014783394,0.008150334,0.16324265],"study_design_scores_gemma":[0.019116493,0.02775202,0.90283227,0.0020210643,0.018802525,0.00070374587,0.00026147044,0.005995581,0.0040626866,0.0030530111,0.015241739,0.0001575007],"about_ca_topic_score_codex":0.0002858306,"about_ca_topic_score_gemma":0.00070854893,"teacher_disagreement_score":0.06406603,"about_ca_system_score_codex":0.0006232258,"about_ca_system_score_gemma":0.000714827,"threshold_uncertainty_score":0.33881766},"labels":[],"label_agreement":null},{"id":"W3034088199","doi":"10.1080/09546634.2020.1781757","title":"The application of medical scale in the treatment of plantar warts: analysis and prospect","year":2020,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Genital Health and Disease","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Plantar warts; Medicine; Cryotherapy; Adverse effect; Conjoint analysis; Quality of life (healthcare); Physical therapy; Dermatology; Surgery; Internal medicine","score_opus":0.050695712007191834,"score_gpt":0.3981674252087829,"score_spread":0.3474717132015911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034088199","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000075954034,0.9993517,0.000042662745,0.00012714656,0.00008054489,0.000003893806,0.0000060545526,0.0000017819291,0.00031022675],"genre_scores_gemma":[0.00053548085,0.9989648,0.00015614495,0.00013199104,0.000071996306,0.000005200103,0.000010449264,7.9359313e-7,0.00012310334],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996307,0.0000988285,0.00007352735,0.00005102478,0.0001226056,0.000023244],"domain_scores_gemma":[0.9993432,0.00043017417,0.00007136045,0.000014655479,0.00011949397,0.000021073842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090135913,0.0006643824,0.0015085714,0.0028595154,0.0002877259,0.0009910398,0.0007547724,0.0009827927,0.0025380333],"category_scores_gemma":[0.0013182755,0.00030669334,0.0012486909,0.0025706321,0.0005609585,0.0014632033,0.0004920142,0.0016111403,0.00075039227],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108353415,0.00009421291,0.00029375387,0.049715854,0.0002251196,0.00023243918,0.0000998286,0.00021668542,0.0008603154,0.0026702618,0.012425956,0.9330572],"study_design_scores_gemma":[0.00008580304,0.00035208947,0.003390026,0.026695319,0.0007856748,0.0036479074,0.00022010178,0.00025466838,0.0007488429,0.0025534898,0.96120894,0.00005708453],"about_ca_topic_score_codex":0.0011392068,"about_ca_topic_score_gemma":0.0020564399,"teacher_disagreement_score":0.0028595154,"about_ca_system_score_codex":0.0005328168,"about_ca_system_score_gemma":0.000992904,"threshold_uncertainty_score":0.008490562},"labels":[],"label_agreement":null},{"id":"W3041882876","doi":"10.1080/09546634.2020.1795061","title":"A systematic review of antipsychotic agents for primary delusional infestation","year":2020,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Body Image and Dysmorphia Studies","field":"Psychology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; Queen's University","funders":"","keywords":"Medicine; Risperidone; PsycINFO; Olanzapine; Antipsychotic; MEDLINE; Psychiatry; Atypical antipsychotic; Pimozide; Systematic review; Schizophrenia (object-oriented programming); Haloperidol; Internal medicine","score_opus":0.121951001454607,"score_gpt":0.43242273202967957,"score_spread":0.3104717305750726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041882876","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045473006,0.99885154,0.000045838988,0.0000819269,0.000058150574,0.00013154656,0.00010884242,0.000004660867,0.00026274298],"genre_scores_gemma":[0.0048329085,0.9943598,0.00026125653,0.00019220231,0.000037852944,0.00015462414,0.000073947405,0.0000019963322,0.00008555557],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9969837,0.0010228631,0.0010849647,0.00019070774,0.0006111107,0.000106578475],"domain_scores_gemma":[0.9928879,0.0047254143,0.001491271,0.000085834225,0.0006858272,0.00012388699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035304069,0.0014187098,0.0060344003,0.0065099755,0.0005703228,0.001744992,0.0015539689,0.0013488728,0.006088206],"category_scores_gemma":[0.012778398,0.00065189705,0.0053049815,0.0073898993,0.0005649156,0.0013100273,0.0009774477,0.0009821183,0.00036357742],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022351134,0.000016383947,0.0002124682,0.9419172,0.004491409,0.00011028878,0.000095241216,0.000063743864,0.00013345033,0.00014688988,0.0015789553,0.051010504],"study_design_scores_gemma":[0.00050027727,0.0004087229,0.0030127226,0.8847554,0.07029576,0.0006837214,0.00025042892,0.00009089798,0.0002462982,0.0003357257,0.039386097,0.000034000903],"about_ca_topic_score_codex":0.006458442,"about_ca_topic_score_gemma":0.02116834,"teacher_disagreement_score":0.0065099755,"about_ca_system_score_codex":0.0025694622,"about_ca_system_score_gemma":0.0066043995,"threshold_uncertainty_score":0.020367026},"labels":[],"label_agreement":null},{"id":"W3042689359","doi":"10.1080/09546634.2020.1782817","title":"Continuous treatment with guselkumab maintains clinical responses through 4 years in patients with moderate-to-severe psoriasis: results from VOYAGE 1","year":2020,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Janssen Research and Development","keywords":"Medicine; Psoriasis; Internal medicine; Placebo; Clinical trial; Dermatology; Adalimumab; Gastroenterology; Surgery; Rheumatoid arthritis","score_opus":0.04617964588141407,"score_gpt":0.2791858588932267,"score_spread":0.23300621301181265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042689359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99597883,0.0031885651,0.00015770404,0.0000924123,0.000023752007,0.00008510068,0.000114494396,0.000022576505,0.00033644956],"genre_scores_gemma":[0.99789256,0.000688398,0.00030888405,0.00019725059,0.0000524419,0.00008700361,0.0003488959,0.000011396565,0.0004131871],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991416,0.00046694293,0.000047329828,0.00011708605,0.000090258356,0.00013684908],"domain_scores_gemma":[0.99854314,0.00044205232,0.0003560104,0.00025559432,0.000077001016,0.00032616302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030726679,0.00039362285,0.0016249748,0.00020488515,0.00029394677,0.00085342536,0.0005403166,0.0006801789,0.0015383338],"category_scores_gemma":[0.0016731803,0.00022127267,0.0015552945,0.0002714896,0.00046221525,0.0005943635,0.00036949306,0.0015466874,0.0003438965],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67814624,0.02224755,0.032226928,0.00068575394,0.0025119614,0.00010069063,0.00046245457,0.0015481118,0.025268406,0.00015741376,0.0018300422,0.23481448],"study_design_scores_gemma":[0.2435421,0.5211732,0.22262654,0.00014910464,0.0018398074,0.00041914632,0.00019247495,0.001783927,0.0046090884,0.0002630216,0.0033413467,0.000060381302],"about_ca_topic_score_codex":0.00055033254,"about_ca_topic_score_gemma":0.0007087279,"teacher_disagreement_score":0.0030726679,"about_ca_system_score_codex":0.0004392247,"about_ca_system_score_gemma":0.00045323686,"threshold_uncertainty_score":0.016250014},"labels":[],"label_agreement":null},{"id":"W3043733200","doi":"10.1080/09546634.2020.1793891","title":"Cost per responder analysis of guselkumab versus targeted therapies in the treatment of moderate to severe plaque psoriasis in Germany","year":2020,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Secukinumab; Psoriasis Area and Severity Index; Psoriasis; Adalimumab; Dermatology; Adverse effect; Internal medicine; Psoriatic arthritis; Rheumatoid arthritis","score_opus":0.07257574718631102,"score_gpt":0.3027416133475172,"score_spread":0.23016586616120618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043733200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90973055,0.0702571,0.006485799,0.002600972,0.0002617837,0.0006453456,0.0068854457,0.00012313887,0.003009845],"genre_scores_gemma":[0.99254274,0.004093889,0.00116376,0.0003011134,0.00004031939,0.00018388097,0.0011398689,0.00001648313,0.0005179879],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99469596,0.0042733727,0.0001641403,0.00031163864,0.00030380237,0.00025117598],"domain_scores_gemma":[0.99395317,0.004563539,0.00097340957,0.00020189403,0.0001581526,0.00014979485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011131284,0.0010820879,0.0028764259,0.0015015232,0.00018505187,0.0017447377,0.0013849812,0.0011574368,0.002389228],"category_scores_gemma":[0.010681839,0.00079120765,0.011195411,0.0014096717,0.0003711414,0.0010729352,0.00081153604,0.0012925311,0.00016134953],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07694855,0.0015341725,0.054454394,0.009573868,0.11158241,0.00062920776,0.00015514932,0.6533835,0.0011598198,0.008705483,0.0053480132,0.07652545],"study_design_scores_gemma":[0.026674027,0.022012517,0.1686339,0.003558135,0.24388298,0.0008785894,0.0005219887,0.5086824,0.0030710637,0.011261604,0.010434209,0.0003886211],"about_ca_topic_score_codex":0.017968321,"about_ca_topic_score_gemma":0.009738739,"teacher_disagreement_score":0.017968321,"about_ca_system_score_codex":0.0066543063,"about_ca_system_score_gemma":0.0023543648,"threshold_uncertainty_score":0.058868587},"labels":[],"label_agreement":null},{"id":"W3044999761","doi":"10.1080/09546634.2020.1801973","title":"Antimalarial therapy for granuloma annulare: a systematic review","year":2020,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Skin Diseases and Diabetes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Granuloma annulare; Medicine; Dermatology","score_opus":0.08982683859480238,"score_gpt":0.39812284711507157,"score_spread":0.30829600852026917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044999761","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004882845,0.9989863,0.00003919973,0.000108999004,0.000067445195,0.000057043108,0.000109480105,0.0000038956427,0.00013937063],"genre_scores_gemma":[0.0074190227,0.9917664,0.00019378953,0.0003027358,0.000053632757,0.00009557198,0.00009260442,0.0000017725574,0.000074464624],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9978289,0.00085588085,0.0006157765,0.00016521836,0.00043202235,0.00010214486],"domain_scores_gemma":[0.9928149,0.005158378,0.0012230051,0.000086736,0.0006041182,0.00011279866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031667645,0.0011289207,0.005875897,0.0029719197,0.0004144692,0.0012682194,0.0013604461,0.001527266,0.004486067],"category_scores_gemma":[0.013995886,0.00062573125,0.005605992,0.0035195935,0.000462509,0.0011824612,0.00089010334,0.0010591581,0.0003649759],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040055157,0.000022976319,0.0005930369,0.9255345,0.012261139,0.000080905185,0.000091679685,0.000104368715,0.00014867818,0.0001852408,0.0039525703,0.056624375],"study_design_scores_gemma":[0.0010462294,0.0005063335,0.0077407914,0.7840487,0.16844599,0.0006276092,0.00024249217,0.00018032831,0.0002657879,0.00042793187,0.03641613,0.00005170002],"about_ca_topic_score_codex":0.0068085184,"about_ca_topic_score_gemma":0.022111729,"teacher_disagreement_score":0.0068085184,"about_ca_system_score_codex":0.0016149806,"about_ca_system_score_gemma":0.0038475865,"threshold_uncertainty_score":0.016747653},"labels":[],"label_agreement":null},{"id":"W3046057178","doi":"10.1080/09546634.2020.1800571","title":"Health state utility values derived from EQ-5D in psoriatic patients: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Psoriasis; Psoriatic arthritis; Medicine; EQ-5D; Psoriasis Area and Severity Index; Dermatology Life Quality Index; Dermatology; Meta-analysis; Quality of life (healthcare); Plaque psoriasis; Physical therapy; Internal medicine; Health related quality of life; Disease","score_opus":0.6690066283858982,"score_gpt":0.47750791437737444,"score_spread":0.19149871400852375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046057178","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030527522,0.9949608,0.00071463437,0.0001832073,0.000084186955,0.00021996287,0.00058110134,0.000019857465,0.00018347167],"genre_scores_gemma":[0.20373571,0.7876954,0.0042027566,0.0009601031,0.00038691788,0.0017059639,0.0011409571,0.00003305902,0.00013902792],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98085105,0.010623697,0.0043461537,0.0016684341,0.0021047653,0.00040582914],"domain_scores_gemma":[0.96849144,0.024009539,0.0048420127,0.000887509,0.0015977295,0.00017178536],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.027915088,0.003152545,0.019019077,0.010997435,0.00054176163,0.0036097101,0.0019392697,0.0017314407,0.0022925732],"category_scores_gemma":[0.056301475,0.00142462,0.03840886,0.009473145,0.0009217735,0.0016419417,0.0013695152,0.0017719225,0.00017908517],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013860475,0.00003165362,0.0074747275,0.41533774,0.5490621,0.000107032785,0.00007289805,0.0014199326,0.00017141431,0.0002962155,0.0008372742,0.023803053],"study_design_scores_gemma":[0.000891686,0.00028602238,0.0082047,0.05105159,0.93528193,0.0002218928,0.00004883155,0.0006269258,0.00022713446,0.00078290055,0.0023249155,0.000051447438],"about_ca_topic_score_codex":0.004501086,"about_ca_topic_score_gemma":0.007444147,"teacher_disagreement_score":0.98098093,"about_ca_system_score_codex":0.0031440656,"about_ca_system_score_gemma":0.0035450223,"threshold_uncertainty_score":0.14763087},"labels":[],"label_agreement":null},{"id":"W3049127020","doi":"10.1080/09546634.2020.1810607","title":"Onychomycosis in children – review on treatment and management strategies","year":2020,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Mediprobe Research (Canada); Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Terbinafine; Itraconazole; Dermatology; Fluconazole; Dermatophyte; Antifungal; Venereology; Griseofulvin; Dosing; Nail disease; Pharmacology; Paronychia","score_opus":0.06830569727389431,"score_gpt":0.38623893664439507,"score_spread":0.3179332393705008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049127020","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014582032,0.9994388,0.000015562491,0.000089127134,0.000039919578,0.00000831305,0.000041825948,0.0000016487435,0.00021892709],"genre_scores_gemma":[0.001270052,0.9984187,0.00008957459,0.00010067166,0.000040334133,0.00000899711,0.000042035008,5.938812e-7,0.000029017752],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991301,0.00019405765,0.00034068603,0.00009986602,0.0001882847,0.00004709996],"domain_scores_gemma":[0.9978715,0.0013392561,0.000538302,0.000024690711,0.00018002136,0.00004630109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091369345,0.0007458033,0.0017959158,0.0035271116,0.00027024277,0.0010382724,0.0008902314,0.00081520755,0.0039835963],"category_scores_gemma":[0.003593176,0.00033141888,0.001694104,0.0037978587,0.00033949575,0.0011488458,0.00050294737,0.0007755225,0.00040148947],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018230769,0.00005566543,0.0016484192,0.45538482,0.0012799716,0.0004702802,0.0002023632,0.00026992557,0.0003448577,0.0009395294,0.018347017,0.52087486],"study_design_scores_gemma":[0.00014817834,0.00030636694,0.011160273,0.5706197,0.008405991,0.0067007923,0.0004964238,0.00012025888,0.0003987765,0.0007447732,0.40085346,0.000044935623],"about_ca_topic_score_codex":0.0035704514,"about_ca_topic_score_gemma":0.005586046,"teacher_disagreement_score":0.0039835963,"about_ca_system_score_codex":0.0009195033,"about_ca_system_score_gemma":0.0026089277,"threshold_uncertainty_score":0.0133264065},"labels":[],"label_agreement":null},{"id":"W3094082904","doi":"10.1080/09546634.2020.1840502","title":"Antihistamines-refractory chronic pruritus in psoriatic patients undergoing biologics: aprepitant vs antihistamine double dosage, a real-world data","year":2020,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Medicine; Aprepitant; Psoriasis; Antihistamine; Refractory (planetary science); Psoriatic arthritis; Internal medicine; Dermatology; Apremilast; Gastroenterology; Anesthesia; Pharmacology; Chemotherapy; Antiemetic","score_opus":0.06610967567425224,"score_gpt":0.293384985865162,"score_spread":0.22727531019090974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094082904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959841,0.002258653,0.00020793552,0.00004622378,0.000018743025,0.00017918546,0.0006798494,0.0000044673393,0.00062090455],"genre_scores_gemma":[0.9983713,0.00039547434,0.00025150587,0.000060804665,0.000041861193,0.0000852142,0.0006885522,0.0000014147623,0.00010372273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979663,0.0010621273,0.00029619812,0.00026019613,0.0003082618,0.00010691023],"domain_scores_gemma":[0.9934714,0.0033766942,0.0020069934,0.00036072193,0.00032338465,0.0004607229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026882705,0.0002502588,0.00086053193,0.00047411842,0.00028568457,0.0005422601,0.00023204832,0.000588932,0.0035854196],"category_scores_gemma":[0.0043058842,0.00014204584,0.0009144407,0.00044837457,0.00037222283,0.00057199487,0.0003304043,0.0005106817,0.00033763304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29711735,0.008811935,0.6044158,0.003130513,0.0028912642,0.0007943901,0.00047557752,0.0007758301,0.0071214586,0.00022548357,0.001493267,0.072747126],"study_design_scores_gemma":[0.0158927,0.12576844,0.84110993,0.00031620165,0.0025106794,0.003979386,0.0007760951,0.0027774947,0.0023834694,0.00024278299,0.004167808,0.000075013675],"about_ca_topic_score_codex":0.0003831623,"about_ca_topic_score_gemma":0.000502348,"teacher_disagreement_score":0.0035854196,"about_ca_system_score_codex":0.00031659173,"about_ca_system_score_gemma":0.00031837632,"threshold_uncertainty_score":0.014217138},"labels":[],"label_agreement":null},{"id":"W3109355046","doi":"10.1080/09546634.2020.1839008","title":"Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials","year":2020,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cilag; LEO Pharma; Sanofi Genzyme; Incyte; Medac; XBiotech; Kiniksa Pharmaceuticals; Fresenius Medical Care North America; Dermira; UCB Pharma; Regeneron Pharmaceuticals; Les Laboratories Pierre Fabre; Biogen; Celgene; Samsung; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer; Galderma; Eli Lilly and Company; GlaxoSmithKline","keywords":"Medicine; Atopic dermatitis; Dermatology; Randomized controlled trial; Corticosteroid; Surgery","score_opus":0.032958681508670706,"score_gpt":0.3156504988386487,"score_spread":0.282691817329978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109355046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95150995,0.03751727,0.00040163725,0.0011485277,0.0002880106,0.0031451944,0.003137459,0.00006550222,0.0027865407],"genre_scores_gemma":[0.98453265,0.008700712,0.0006256485,0.00108553,0.00022451757,0.0017270665,0.0023083058,0.000009758963,0.00078584737],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99892277,0.0005855578,0.00014220453,0.00012297461,0.00012490641,0.00010155139],"domain_scores_gemma":[0.9980058,0.0006410263,0.0007407419,0.000115736344,0.00019038527,0.00030631231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030972725,0.0007980779,0.0022895345,0.000353759,0.00033925264,0.0012452791,0.0005990963,0.0013331827,0.0030427233],"category_scores_gemma":[0.0031797907,0.00030298784,0.002703943,0.00073256623,0.0004976647,0.00057733024,0.00029351216,0.0012655341,0.00030590312],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8971375,0.0048671197,0.0119454665,0.0044952794,0.014619034,0.00010095371,0.000098952,0.0005477821,0.004452917,0.00010684345,0.0032770825,0.058351073],"study_design_scores_gemma":[0.86518955,0.07477239,0.04451397,0.00039342075,0.011039716,0.00021593306,0.00007636224,0.00060986757,0.0007884674,0.00014119405,0.0022128127,0.000046217156],"about_ca_topic_score_codex":0.0009996812,"about_ca_topic_score_gemma":0.0035949568,"teacher_disagreement_score":0.0030972725,"about_ca_system_score_codex":0.0008169327,"about_ca_system_score_gemma":0.00094232504,"threshold_uncertainty_score":0.016380131},"labels":[],"label_agreement":null},{"id":"W3157474078","doi":"10.1080/09546634.2021.1927949","title":"Efficacy of non-surgical monotherapies for hidradenitis suppurativa: a systematic review and network meta-analyses of randomized trials","year":2021,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Mediprobe Research (Canada); Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Placebo; Hidradenitis suppurativa; Anakinra; Infliximab; Adalimumab; Randomized controlled trial; Flucloxacillin; Internal medicine; Surgery; Meta-analysis; Disease","score_opus":0.3801484934765829,"score_gpt":0.49827773216139926,"score_spread":0.11812923868481634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157474078","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052348073,0.99256104,0.00073439913,0.00021888787,0.0001372891,0.0002900432,0.00055054727,0.000023758113,0.00024919206],"genre_scores_gemma":[0.33280605,0.65687686,0.0051601273,0.0011867008,0.0004343593,0.001780828,0.0013861745,0.000055086566,0.00031384223],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9737613,0.016623737,0.0049526547,0.0022473142,0.001962767,0.00045220077],"domain_scores_gemma":[0.9435601,0.045717485,0.0065191407,0.0015364914,0.0022081444,0.00045860972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028220594,0.0031250892,0.019969584,0.009353067,0.00061590434,0.0032695697,0.0020537544,0.0020783977,0.0033291993],"category_scores_gemma":[0.053365763,0.00147213,0.040067088,0.007543571,0.00090109167,0.0020156337,0.0018177651,0.002047134,0.00027581846],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020891705,0.00002528691,0.0030467303,0.21095945,0.7723648,0.00006179288,0.00004511182,0.0005344733,0.00013414295,0.00013087268,0.00036475973,0.010243339],"study_design_scores_gemma":[0.0009032877,0.00025440197,0.003118971,0.016334994,0.9774465,0.000074730866,0.00003128978,0.00028603757,0.00008406938,0.0002957476,0.0011515347,0.000018371382],"about_ca_topic_score_codex":0.004911857,"about_ca_topic_score_gemma":0.009928053,"teacher_disagreement_score":0.028220594,"about_ca_system_score_codex":0.0027447413,"about_ca_system_score_gemma":0.0029245398,"threshold_uncertainty_score":0.14924657},"labels":[],"label_agreement":null},{"id":"W3159131528","doi":"10.1080/09546634.2021.1902925","title":"Efficacy, tolerability, patient usability, and satisfaction with a 2 mL pre-filled syringe containing secukinumab 300 mg in patients with moderate to severe plaque psoriasis: results from the phase 3 randomized, double-blind, placebo-controlled ALLURE study","year":2021,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; University of British Columbia","funders":"","keywords":"Secukinumab; Medicine; Tolerability; Placebo; Psoriasis Area and Severity Index; Psoriasis; Bioequivalence; Randomized controlled trial; Clinical endpoint; Adverse effect; Internal medicine; Pharmacokinetics; Dermatology; Psoriatic arthritis; Pathology","score_opus":0.023625956233543143,"score_gpt":0.2691566812626643,"score_spread":0.24553072502912116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159131528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99724716,0.0013856031,0.00023816607,0.00009105688,0.000025451012,0.000491398,0.0001492637,0.000029216599,0.00034258977],"genre_scores_gemma":[0.99785644,0.0005901,0.00048830843,0.00019932294,0.0000596261,0.00037123504,0.00015573642,0.0000051590155,0.00027412525],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99910295,0.00053047243,0.00006890079,0.000092842136,0.00013255175,0.00007221402],"domain_scores_gemma":[0.9987697,0.0004196828,0.00045238226,0.000082240105,0.000068765046,0.00020705309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001955064,0.0006956689,0.0015942164,0.0002193632,0.00034577397,0.0005084232,0.00048623525,0.0008118922,0.0033342424],"category_scores_gemma":[0.001418855,0.00038766974,0.001339577,0.00024655752,0.0006200664,0.0006025643,0.00024240634,0.00147843,0.0003618109],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7727521,0.063463934,0.011202007,0.0022135999,0.0026718637,0.000115280236,0.00038307134,0.0006969704,0.034472007,0.000091467926,0.0010659158,0.11087179],"study_design_scores_gemma":[0.37471676,0.5746591,0.044016927,0.000057330908,0.0011764425,0.00020191415,0.00009328036,0.0008776566,0.003433657,0.00006948853,0.00065920706,0.0000382961],"about_ca_topic_score_codex":0.00030758497,"about_ca_topic_score_gemma":0.0007527902,"teacher_disagreement_score":0.0033342424,"about_ca_system_score_codex":0.0003168384,"about_ca_system_score_gemma":0.0004100513,"threshold_uncertainty_score":0.011154175},"labels":[],"label_agreement":null},{"id":"W3164549179","doi":"10.1080/09546634.2021.1937480","title":"Data mining for detecting signals of adverse drug reaction of doxycycline using the Korea adverse event reporting system database","year":2021,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Adverse effect; Pharmacovigilance; Malaise; Adverse drug reaction; Doxycycline; Dermatology; Adverse Event Reporting System; Hyperpigmentation; Internal medicine; Paronychia; Database; Surgery; Drug; Antibiotics; Pharmacology","score_opus":0.3452900453759856,"score_gpt":0.4972952069914539,"score_spread":0.1520051616154683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164549179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6395812,0.004796623,0.04779315,0.0015687098,0.00023410628,0.0035822033,0.29483613,0.003652788,0.0039551333],"genre_scores_gemma":[0.6081443,0.001992261,0.11148109,0.00041324447,0.000108328044,0.0029211987,0.2739524,0.00006621664,0.0009209079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954991,0.0006107698,0.0018215827,0.0009975736,0.00088602834,0.00018497401],"domain_scores_gemma":[0.98941165,0.0036342258,0.0034474442,0.00085070706,0.002214801,0.00044111675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004093361,0.00091330963,0.0011915301,0.008505575,0.00046628856,0.0012896004,0.0011778752,0.00081440114,0.0011665517],"category_scores_gemma":[0.010667181,0.00027642975,0.001436577,0.0055809123,0.0002161781,0.0009742685,0.0009098519,0.0007688415,0.00050159363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019533762,0.0010868775,0.6873643,0.006519412,0.0017098314,0.004852987,0.0006154762,0.014583495,0.011206845,0.00183061,0.033155102,0.23512171],"study_design_scores_gemma":[0.00075574836,0.0020180708,0.6636211,0.0012703359,0.0021678712,0.005092742,0.001933656,0.21990839,0.026594607,0.0035889507,0.07270825,0.00034024898],"about_ca_topic_score_codex":0.0055519673,"about_ca_topic_score_gemma":0.00551612,"teacher_disagreement_score":0.008505575,"about_ca_system_score_codex":0.0008208847,"about_ca_system_score_gemma":0.0025710235,"threshold_uncertainty_score":0.02164805},"labels":[],"label_agreement":null},{"id":"W3174298125","doi":"10.1080/09546634.2021.1945527","title":"Minoxidil: a comprehensive review","year":2021,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Minoxidil; Dermatology","score_opus":0.1795974074302688,"score_gpt":0.4393575185586624,"score_spread":0.2597601111283936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174298125","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017256015,0.9981609,0.00006562575,0.00027676017,0.0002456413,0.00001203188,0.000063675594,0.000011621873,0.0009911403],"genre_scores_gemma":[0.0012688655,0.9971163,0.0001782269,0.00031010484,0.00031139606,0.000016301925,0.00012753237,0.0000032418193,0.0006680909],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997569,0.000038727176,0.00005932464,0.000048037702,0.00006995333,0.000027087335],"domain_scores_gemma":[0.9995759,0.00017822933,0.00008762632,0.000013634237,0.00010235054,0.000042280644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059446093,0.00081420917,0.001387703,0.002993959,0.00035376946,0.0012317818,0.0011479629,0.0010346145,0.010764772],"category_scores_gemma":[0.00094375544,0.00027559503,0.0010389785,0.0019503847,0.0002761845,0.001278251,0.0007124294,0.0014022252,0.0031236382],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019205287,0.00010937084,0.00024639882,0.046441533,0.00017910005,0.00028227305,0.000060746283,0.00018515927,0.0011369622,0.0012177909,0.0412484,0.90870035],"study_design_scores_gemma":[0.000060464838,0.00028926574,0.001296435,0.012713367,0.0006257285,0.0026258882,0.000068256464,0.00011561337,0.0006414194,0.00071620115,0.9808146,0.000032768337],"about_ca_topic_score_codex":0.00095511385,"about_ca_topic_score_gemma":0.0015774972,"teacher_disagreement_score":0.010764772,"about_ca_system_score_codex":0.0004665476,"about_ca_system_score_gemma":0.0014838652,"threshold_uncertainty_score":0.036011755},"labels":[],"label_agreement":null},{"id":"W3187307731","doi":"10.1080/09546634.2021.1959501","title":"Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysis","year":2021,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University; Probity Medical Research","funders":"LEO Pharma","keywords":"Medicine; Psoriasis; Clinical endpoint; Hazard ratio; Internal medicine; Adverse effect; Gastroenterology; Dermatology; Randomized controlled trial; Confidence interval","score_opus":0.023649579152604096,"score_gpt":0.2408794334713459,"score_spread":0.2172298543187418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187307731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951428,0.003811326,0.00025699244,0.000056659137,0.00004327097,0.00014233324,0.00023400834,0.000007976428,0.00030465826],"genre_scores_gemma":[0.9986803,0.00046428325,0.00015204835,0.000059931863,0.00006783603,0.00010474345,0.00029176153,0.0000029778278,0.00017612518],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991104,0.00034123502,0.00014871969,0.0001762096,0.0001227137,0.00010064558],"domain_scores_gemma":[0.99918073,0.00032533956,0.00020260933,0.000116618685,0.000065584245,0.000109027504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001629837,0.0006623492,0.0025621878,0.0003057725,0.00021285872,0.00061428867,0.00035391218,0.0007122393,0.0013865214],"category_scores_gemma":[0.001398298,0.00025026596,0.0041569285,0.0003189876,0.00026422375,0.00051473087,0.00037842948,0.00066767767,0.0001783786],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74301714,0.0019856961,0.16016924,0.0014449569,0.029530017,0.00042551762,0.0002023686,0.0008418016,0.013302296,0.00007966894,0.0005100223,0.04849117],"study_design_scores_gemma":[0.087455645,0.2005962,0.6507948,0.00017873409,0.047810245,0.0010690523,0.00059483334,0.004428395,0.003645475,0.00038365388,0.0029077486,0.00013534588],"about_ca_topic_score_codex":0.0003615892,"about_ca_topic_score_gemma":0.0008469675,"teacher_disagreement_score":0.0025621878,"about_ca_system_score_codex":0.00027127902,"about_ca_system_score_gemma":0.00030211126,"threshold_uncertainty_score":0.008619547},"labels":[],"label_agreement":null},{"id":"W3190122872","doi":"10.1080/09546634.2021.1959504","title":"Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study","year":2021,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Guenther Dermatology Research Centre; Probity Medical Research; Dalhousie University","funders":"","keywords":"Secukinumab; Medicine; Plaque psoriasis; Dermatology; Psoriasis; Psoriatic arthritis","score_opus":0.03732038913152342,"score_gpt":0.2685031290800881,"score_spread":0.2311827399485647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190122872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99745864,0.0017047456,0.000057022724,0.0000929269,0.000029144696,0.000058214868,0.000115639246,0.000007402588,0.00047636934],"genre_scores_gemma":[0.9984769,0.0005820262,0.00012177464,0.000121598125,0.00005026343,0.000072737435,0.00025696997,0.000003379282,0.00031434844],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99934953,0.00035824475,0.000050879542,0.000077868455,0.00007180854,0.000091638394],"domain_scores_gemma":[0.9993081,0.00021753472,0.00015812033,0.00006313607,0.000044289583,0.00020884688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019347122,0.00048433404,0.0015370754,0.00019912217,0.00024557262,0.0005557251,0.00028855746,0.0004957429,0.0017341311],"category_scores_gemma":[0.0013515365,0.0002066576,0.0012077729,0.000192561,0.00030441675,0.0003786608,0.00028135462,0.00091824523,0.00030234348],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87801516,0.009732031,0.025600344,0.00039441366,0.0016454768,0.00006393369,0.0001466217,0.00037708093,0.009116256,0.00008213336,0.00082729163,0.07399922],"study_design_scores_gemma":[0.357916,0.34058625,0.2895772,0.00013452853,0.0032647874,0.0004113465,0.0002287119,0.0015110533,0.0031674928,0.00018304036,0.002971142,0.00004855004],"about_ca_topic_score_codex":0.0004740906,"about_ca_topic_score_gemma":0.0011975745,"teacher_disagreement_score":0.0019347122,"about_ca_system_score_codex":0.00044749564,"about_ca_system_score_gemma":0.0004312733,"threshold_uncertainty_score":0.0102318525},"labels":[],"label_agreement":null},{"id":"W3193000512","doi":"10.1080/09546634.2021.1967269","title":"Isotretinoin for acne vulgaris – an update on adverse effects and laboratory monitoring","year":2021,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Isotretinoin; Medicine; Adverse effect; Acne; Dermatology; Mucocutaneous zone; Confusion; Intensive care medicine; Disease; Internal medicine","score_opus":0.06410575999496682,"score_gpt":0.39910592866676253,"score_spread":0.3350001686717957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193000512","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007634975,0.9993525,0.00003236063,0.00019161787,0.00007949119,0.0000047798076,0.000019826304,0.000003215809,0.00023989636],"genre_scores_gemma":[0.0006437602,0.9987966,0.00012050358,0.00017841301,0.000110830515,0.000005385916,0.000030837105,0.0000011814375,0.00011252485],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991893,0.00018449953,0.0002491852,0.00007233144,0.00027396262,0.000030766114],"domain_scores_gemma":[0.99723417,0.0018510186,0.00040225606,0.000044760807,0.00042027902,0.0000475271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013112588,0.00073822873,0.001928889,0.003053466,0.00025161944,0.0011798099,0.00086614233,0.0011821492,0.0046542794],"category_scores_gemma":[0.0036090587,0.00030647297,0.0017106063,0.0027383037,0.00034786228,0.0013524585,0.00055421126,0.0013737523,0.0007640517],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012394023,0.000069247915,0.00043025246,0.08804663,0.0005179022,0.00027288092,0.000101280246,0.0001849683,0.00049866195,0.0008944905,0.024182532,0.8846772],"study_design_scores_gemma":[0.00009812343,0.00026881247,0.0042424854,0.10103465,0.0033475743,0.0051628873,0.00016702441,0.00019473962,0.00040531447,0.0018355234,0.88319236,0.000050598712],"about_ca_topic_score_codex":0.0020403157,"about_ca_topic_score_gemma":0.0040227287,"teacher_disagreement_score":0.0046542794,"about_ca_system_score_codex":0.00053425576,"about_ca_system_score_gemma":0.0012888974,"threshold_uncertainty_score":0.015570164},"labels":[],"label_agreement":null},{"id":"W4220705068","doi":"10.1080/09546634.2022.2049589","title":"Time to codify a challenge in communication","year":2022,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Medical care; Medical practice; Medical literature; Intensive care medicine; Resistance (ecology); MEDLINE; Immunization; Health care; Family medicine; Immunology; Pathology","score_opus":0.2766925474117619,"score_gpt":0.4399309135712461,"score_spread":0.16323836615948417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220705068","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09806082,0.014335625,0.068414085,0.48415884,0.025176385,0.00047105382,0.0002202731,0.0012035114,0.30795944],"genre_scores_gemma":[0.76538783,0.0070832,0.052912273,0.07701758,0.007029831,0.0004419489,0.00027625274,0.0006355355,0.08921551],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99266374,0.0037285658,0.00040569442,0.00047124678,0.0019137731,0.00081697234],"domain_scores_gemma":[0.98558074,0.006195097,0.0013059337,0.00093882607,0.002574333,0.0034051042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058927303,0.00058780034,0.00051058485,0.0008169973,0.005163624,0.009358865,0.0011872811,0.0051390673,0.015160565],"category_scores_gemma":[0.024777625,0.00032862468,0.0006733005,0.00040672833,0.0062822085,0.012159134,0.0074022952,0.010555716,0.0055364664],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038564726,0.000398554,0.007956103,0.0011311758,0.000104761675,0.020260802,0.27594417,0.00039504233,0.018725753,0.20946318,0.15441237,0.3108224],"study_design_scores_gemma":[0.000043454147,0.00027183798,0.00347526,0.0015208364,0.00003520078,0.021728085,0.10591153,0.00061986124,0.0020434372,0.069687024,0.79452187,0.00014160814],"about_ca_topic_score_codex":0.0016874807,"about_ca_topic_score_gemma":0.0018295873,"teacher_disagreement_score":0.015160565,"about_ca_system_score_codex":0.0026850277,"about_ca_system_score_gemma":0.0068107247,"threshold_uncertainty_score":0.050717115},"labels":[],"label_agreement":null},{"id":"W4281294257","doi":"10.1080/09546634.2022.2067814","title":"Preliminary efficacy and safety analysis: 12-month results in 83 patients using a novel approach of widefield radiation therapy for extensive skin field cancerization with or without keratinocyte cancers","year":2022,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Cosmesis; Field cancerization; Dermatology; Skin cancer; Radiation therapy; Clinical trial; Cancer; Surgery; Internal medicine","score_opus":0.04405874643816851,"score_gpt":0.3103970111432307,"score_spread":0.26633826470506217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281294257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988871,0.0003673529,0.00019267568,0.000013603276,0.0000030529984,0.000065966946,0.00013172689,0.0000048797206,0.00033359576],"genre_scores_gemma":[0.9990465,0.00021236902,0.0002346887,0.000034118795,0.000018121516,0.00006653262,0.00026966972,0.000003580398,0.0001144912],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99922216,0.000369417,0.0000851697,0.0001072023,0.00014792407,0.00006813881],"domain_scores_gemma":[0.9985667,0.00047611597,0.00053857145,0.00015901917,0.000088830435,0.00017091581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016987781,0.00035769914,0.00060235354,0.00031702634,0.00031047285,0.0003615337,0.000204282,0.00024844272,0.0010568389],"category_scores_gemma":[0.0014156867,0.00013446681,0.0008294616,0.0003061666,0.00035696573,0.0002615085,0.0002479082,0.00049994973,0.00022108709],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0464898,0.014097103,0.78506374,0.00041040854,0.001788156,0.000683272,0.00057643,0.0030314664,0.021991845,0.000073651776,0.00069777307,0.12509637],"study_design_scores_gemma":[0.0037659078,0.16169563,0.82162845,0.00004052317,0.0012033426,0.0015239997,0.00018239193,0.0015485566,0.00723914,0.000057442212,0.0010923069,0.000022378808],"about_ca_topic_score_codex":0.00054427085,"about_ca_topic_score_gemma":0.00083007984,"teacher_disagreement_score":0.0016987781,"about_ca_system_score_codex":0.00036243093,"about_ca_system_score_gemma":0.00030040377,"threshold_uncertainty_score":0.008984089},"labels":[],"label_agreement":null},{"id":"W4287219390","doi":"10.1080/09546634.2022.2095330","title":"Matching-adjusted indirect comparison of efficacy outcomes in trials of calcipotriol plus betamethasone dipropionate foam and cream formulations for the treatment of plaque psoriasis","year":2022,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"LEO Pharma","keywords":"Medicine; Betamethasone dipropionate; Calcipotriol; Plaque psoriasis; Dermatology; Betamethasone; Psoriasis; Randomized controlled trial; Surgery; Internal medicine","score_opus":0.12532798555622987,"score_gpt":0.36141883211665476,"score_spread":0.2360908465604249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287219390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9519326,0.020360552,0.012069557,0.00046798462,0.00092324655,0.0048293583,0.0043456056,0.00019689504,0.0048743077],"genre_scores_gemma":[0.9872076,0.00066731864,0.0063857757,0.00024795986,0.0000847157,0.0036461733,0.0012309649,0.000021459926,0.00050809834],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9304098,0.059364714,0.004056869,0.0026351577,0.0025277303,0.0010057564],"domain_scores_gemma":[0.96487427,0.027227039,0.004293719,0.002086406,0.0010240754,0.000494546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03265957,0.001764484,0.0034576205,0.0015964631,0.00039176174,0.0013932223,0.0014449374,0.0015813427,0.0049933544],"category_scores_gemma":[0.058019847,0.00054424413,0.008156036,0.0015685905,0.0009545129,0.0009568735,0.0017814034,0.0016515017,0.000256024],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.714159,0.001261471,0.04211562,0.009198124,0.17131999,0.00016702524,0.000374188,0.0049218703,0.0025068417,0.0021888532,0.0015366704,0.050250303],"study_design_scores_gemma":[0.36153716,0.15943024,0.19471927,0.0013168455,0.22298475,0.0006222141,0.00052730134,0.031183943,0.007304436,0.0096784765,0.01035733,0.0003380027],"about_ca_topic_score_codex":0.0014791003,"about_ca_topic_score_gemma":0.0014376136,"teacher_disagreement_score":0.03265957,"about_ca_system_score_codex":0.0010027412,"about_ca_system_score_gemma":0.0009924613,"threshold_uncertainty_score":0.1727224},"labels":[],"label_agreement":null},{"id":"W4289711861","doi":"10.1080/09546634.2022.2109567","title":"Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia","year":2022,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Finasteride; Minoxidil; Dutasteride; Medicine; Hair loss; Male-pattern baldness; Urology; 5 Alpha-Reductase Inhibitor; Dermatology; Dihydrotestosterone; Internal medicine; Pharmacology; Scalp; Androgen; Prostate","score_opus":0.21519005073356512,"score_gpt":0.4474377420550728,"score_spread":0.2322476913215077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289711861","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85001415,0.14260292,0.00056828465,0.0006766418,0.0006376121,0.00032211043,0.00060237723,0.00008103142,0.0044949017],"genre_scores_gemma":[0.9727998,0.024209881,0.00080729526,0.00029007942,0.00020270245,0.00008900728,0.0003686673,0.000013096123,0.0012193545],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9997559,0.00007024801,0.00002843771,0.00004486852,0.00006673618,0.00003371244],"domain_scores_gemma":[0.9996087,0.00013328616,0.00008185572,0.000016281443,0.000049179067,0.00011073366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004762196,0.00031381028,0.0012000753,0.00037274125,0.00012579262,0.0004345694,0.00032229483,0.0002931584,0.003249531],"category_scores_gemma":[0.0007143013,0.00011775111,0.00091772835,0.00022667696,0.00026018865,0.00051578507,0.00016648919,0.0009830217,0.00030262466],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35339347,0.009837959,0.0049456363,0.010469283,0.002818652,0.00029464072,0.00018445794,0.0013933985,0.06959424,0.00060642575,0.0035167942,0.5429451],"study_design_scores_gemma":[0.12406357,0.6887986,0.06617997,0.0016988508,0.01197038,0.0019895788,0.00082326424,0.0056649074,0.05149156,0.0008445628,0.046311833,0.0001629586],"about_ca_topic_score_codex":0.0007452392,"about_ca_topic_score_gemma":0.0029398215,"teacher_disagreement_score":0.003249531,"about_ca_system_score_codex":0.0003418066,"about_ca_system_score_gemma":0.0005040642,"threshold_uncertainty_score":0.010870755},"labels":[],"label_agreement":null},{"id":"W4367048315","doi":"10.1080/09546634.2023.2193663","title":"The clinical relevance of dupilumab serum concentration in patients with atopic dermatitis: a two-center prospective cohort study","year":2023,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"LEO Pharma; Galderma; Sanofi Genzyme; ZonMw; Department of Health and Social Care; National Institute for Health and Care Research; Sanofi; King's College London; Pfizer","keywords":"Dupilumab; Atopic dermatitis; Medicine; Eczema Area and Severity Index; Discontinuation; Adverse effect; Dermatology; Single Center; Internal medicine; Cohort; Clinical trial; Gastroenterology","score_opus":0.021059547196795553,"score_gpt":0.328815252455005,"score_spread":0.30775570525820944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367048315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994018,0.00015301631,0.00007697952,0.000013842506,0.0000043720265,0.000017654236,0.00018990775,0.0000019976396,0.00014028998],"genre_scores_gemma":[0.9994931,0.000051004135,0.000069239984,0.000017378905,0.000007716308,0.000014279051,0.00026600529,0.0000018082864,0.000079404024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988438,0.00030922153,0.00010187499,0.00044100182,0.00014923944,0.00015489229],"domain_scores_gemma":[0.9980757,0.0003754418,0.00070419576,0.00030277987,0.0001948976,0.00034685852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013129915,0.00046085165,0.00059560087,0.00070486736,0.00071014056,0.0010380489,0.000547975,0.0007218221,0.0021388778],"category_scores_gemma":[0.002098837,0.00044873203,0.0008075771,0.00092195574,0.00046088523,0.00062682835,0.0006003386,0.0007699541,0.00037796533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046613193,0.000055744888,0.9985055,0.0000087477365,0.00008218777,0.00008497447,0.00007076277,0.000013826912,0.0002005845,0.000007321915,0.000039790968,0.00046452237],"study_design_scores_gemma":[0.00004570583,0.00044720268,0.9985311,0.000005318212,0.000086765205,0.00041340088,0.00015614698,0.00012219447,0.00006058175,0.000012539029,0.00011256073,0.000006389899],"about_ca_topic_score_codex":0.002856143,"about_ca_topic_score_gemma":0.0022956468,"teacher_disagreement_score":0.002856143,"about_ca_system_score_codex":0.00041765327,"about_ca_system_score_gemma":0.00035230137,"threshold_uncertainty_score":0.007155299},"labels":[],"label_agreement":null},{"id":"W4381469293","doi":"10.1080/09546634.2023.2220446","title":"Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trials","year":2023,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bausch Health; Ortho Dermatologics","keywords":"Adapalene; Tolerability; Benzoyl peroxide; Medicine; Dermatology; Acne; Clindamycin; Sensitization; Adverse effect; Internal medicine; Pharmacology; Antibiotics; Immunology","score_opus":0.13105051433665066,"score_gpt":0.40756252014543665,"score_spread":0.276512005808786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381469293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9609722,0.02748157,0.0012625711,0.00051777385,0.00014226402,0.0034819636,0.0012033639,0.00008472787,0.004853586],"genre_scores_gemma":[0.9855661,0.009513055,0.001275473,0.00038051215,0.00009853479,0.0010768842,0.00092076266,0.000014549412,0.001154228],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99917656,0.00033525255,0.00012468177,0.00011793334,0.00017821028,0.00006729054],"domain_scores_gemma":[0.9986975,0.0004142943,0.000417388,0.00009474521,0.00021349578,0.00016249478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00251092,0.00063147116,0.0009131052,0.0002852714,0.00030773398,0.0006626197,0.00044679895,0.00060890405,0.003269369],"category_scores_gemma":[0.0014707455,0.00026520021,0.0012595862,0.00032589285,0.00038143407,0.00035562078,0.00023236802,0.0010155428,0.00036920066],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28363413,0.028509216,0.014212417,0.01405487,0.006047097,0.00040156097,0.0007265327,0.0011122683,0.21744867,0.0003016659,0.005723614,0.42782798],"study_design_scores_gemma":[0.20501949,0.64518327,0.06480803,0.00117828,0.009088169,0.001719355,0.00029346257,0.00088716956,0.05416988,0.00029413306,0.0172692,0.0000897275],"about_ca_topic_score_codex":0.00042534922,"about_ca_topic_score_gemma":0.0015035099,"teacher_disagreement_score":0.003269369,"about_ca_system_score_codex":0.00041356284,"about_ca_system_score_gemma":0.00074974896,"threshold_uncertainty_score":0.0132792},"labels":[],"label_agreement":null},{"id":"W4385691149","doi":"10.1080/09546634.2023.2245084","title":"Systematic review of mesotherapy: a novel avenue for the treatment of hair loss","year":2023,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Minoxidil; Hair loss; Dermatology; Adverse effect; Hair growth; Clinical trial; Dutasteride; Surgery; Pharmacology; Internal medicine; Physiology","score_opus":0.13334366607385167,"score_gpt":0.4110685831032732,"score_spread":0.27772491702942154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385691149","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003310183,0.9986261,0.000097276796,0.000150647,0.0000968982,0.00014616478,0.00026394127,0.000006444807,0.00028148323],"genre_scores_gemma":[0.0028456927,0.9961434,0.00027561112,0.0002508743,0.000049217993,0.00014946182,0.00014992035,0.0000026266437,0.00013316667],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9976392,0.00064381125,0.00091669976,0.00018775184,0.000532861,0.00007965364],"domain_scores_gemma":[0.9933676,0.004348859,0.001384014,0.0001113096,0.0006913496,0.00009693886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027936287,0.0012290674,0.005180236,0.0079360455,0.0005338714,0.0017074359,0.0013176535,0.0011434887,0.0070647784],"category_scores_gemma":[0.011487366,0.0005243746,0.004644852,0.008506556,0.00048688456,0.0015017606,0.0010136734,0.00076170824,0.0005293513],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110949266,0.000010551206,0.00026199163,0.9448644,0.0035455718,0.000095896234,0.00007148314,0.000062612366,0.00020155276,0.00021943855,0.0024917559,0.048063867],"study_design_scores_gemma":[0.00022441807,0.00022258672,0.0038751808,0.8638131,0.054629523,0.000815924,0.00020541642,0.00008767176,0.00028181475,0.00051863736,0.075287856,0.00003784647],"about_ca_topic_score_codex":0.0058626863,"about_ca_topic_score_gemma":0.018181931,"teacher_disagreement_score":0.0079360455,"about_ca_system_score_codex":0.0018314265,"about_ca_system_score_gemma":0.0076818513,"threshold_uncertainty_score":0.023634076},"labels":[],"label_agreement":null},{"id":"W4385798576","doi":"10.1080/09546634.2023.2245081","title":"Fixed-combination halobetasol propionate and tazarotene topical lotion decreases TNF-α and IL-17A levels in psoriatic lesions","year":2023,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bausch Health; Ortho Dermatologics","keywords":"Medicine; Lotion; Tazarotene; Dermatology; Psoriasis; Clobetasol propionate; Pharmacology","score_opus":0.04533301504517874,"score_gpt":0.27711150266847906,"score_spread":0.23177848762330033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385798576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969202,0.0020082365,0.00043293554,0.000042693424,0.000030075349,0.00003467351,0.000056723646,0.00004791593,0.00042651588],"genre_scores_gemma":[0.99654514,0.001245885,0.0010265332,0.000060890095,0.00004122734,0.000033373835,0.00014407869,0.000007585201,0.00089521],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998536,0.000029206652,0.000011313892,0.000017967324,0.00006118548,0.000026681566],"domain_scores_gemma":[0.99989986,0.000015438727,0.000032630465,0.000007676421,0.000011438389,0.00003296222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020020484,0.00040230228,0.00043565276,0.00023466996,0.0000973628,0.00017668128,0.0001943404,0.0001762369,0.0016164313],"category_scores_gemma":[0.00018033758,0.00015745474,0.00025886734,0.00009718479,0.00015420801,0.0001490592,0.00009461795,0.0005306357,0.0002650301],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051946985,0.0015998331,0.0014898838,0.0001362138,0.00005954805,0.000073481344,0.000024750303,0.0001178124,0.95909625,0.000017834354,0.00019562535,0.03199391],"study_design_scores_gemma":[0.0053449105,0.17729507,0.14840502,0.00007078847,0.000520604,0.0026904906,0.00019957333,0.0029102708,0.65714103,0.00008151705,0.005316011,0.00002471907],"about_ca_topic_score_codex":0.00040755642,"about_ca_topic_score_gemma":0.0012019537,"teacher_disagreement_score":0.0016164313,"about_ca_system_score_codex":0.0001013542,"about_ca_system_score_gemma":0.00013327366,"threshold_uncertainty_score":0.0054074526},"labels":[],"label_agreement":null},{"id":"W4387440451","doi":"10.1080/09546634.2023.2265658","title":"Utility of devices for onychomycosis: a review","year":2023,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Terbinafine; Nail disease; Clinical trial; Dermatology; Antifungal; Psoriasis; Pathology; Itraconazole","score_opus":0.3294596508029908,"score_gpt":0.49670262514355706,"score_spread":0.16724297434056629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387440451","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006147556,0.9995338,0.000025904907,0.00005817997,0.0000436258,0.0000067299407,0.000018373727,0.000002038712,0.00024998598],"genre_scores_gemma":[0.0004242574,0.99929774,0.00007975746,0.000067792316,0.00002685997,0.000005142439,0.000016156986,6.2699434e-7,0.00008171756],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999509,0.000095481635,0.0001345412,0.0000726528,0.00016472938,0.000023528275],"domain_scores_gemma":[0.998838,0.00080952136,0.00016895986,0.000022219554,0.0001343481,0.000026962074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090653426,0.00095406524,0.0020162659,0.0039739734,0.0003102308,0.0012583433,0.0010465981,0.0009732641,0.0067476933],"category_scores_gemma":[0.002187425,0.00036020795,0.0016482506,0.0033665167,0.00041637538,0.0012018112,0.00066895474,0.0009753575,0.0009853133],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120210185,0.00006755268,0.00023978141,0.22070244,0.0005971453,0.00021126217,0.00010641239,0.00020627934,0.00063640566,0.0013374864,0.01526241,0.7605127],"study_design_scores_gemma":[0.00007955555,0.00025553006,0.0028069664,0.16449988,0.0034077445,0.0032074666,0.00022694304,0.0001345704,0.0005441311,0.0016275016,0.8231681,0.000041594878],"about_ca_topic_score_codex":0.001773797,"about_ca_topic_score_gemma":0.0035415865,"teacher_disagreement_score":0.0067476933,"about_ca_system_score_codex":0.00058492244,"about_ca_system_score_gemma":0.0016645686,"threshold_uncertainty_score":0.022573292},"labels":[],"label_agreement":null},{"id":"W4391445529","doi":"10.1080/09546634.2024.2310633","title":"Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adolescents and adults: pooled results from 2 phase 3 studies","year":2024,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Ruxolitinib; Medicine; Atopic dermatitis; Tolerability; Janus kinase inhibitor; Eczema Area and Severity Index; Dermatology; Head and neck; Quality of life (healthcare); Internal medicine; Dupilumab; Janus kinase; Surgery; Adverse effect; Myelofibrosis","score_opus":0.04943712713521411,"score_gpt":0.3647427674632789,"score_spread":0.3153056403280648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391445529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9223821,0.0728934,0.0007907724,0.0001678446,0.000099208104,0.0006565074,0.0010617427,0.00007421831,0.0018742105],"genre_scores_gemma":[0.9911494,0.0071133426,0.00041552185,0.000234144,0.00009061124,0.00013718316,0.0006632641,0.000007991615,0.00018858297],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99835986,0.00078235014,0.0002420679,0.0002206417,0.0003178944,0.00007718184],"domain_scores_gemma":[0.99836224,0.0006041352,0.00062764256,0.0001015189,0.00018631786,0.00011801863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00447598,0.00060301414,0.0021436217,0.00048305898,0.00015797868,0.00069536,0.0003388447,0.00039274112,0.00096532627],"category_scores_gemma":[0.002095479,0.00028733446,0.0028170282,0.00045593307,0.00018734368,0.00036940203,0.00023116259,0.0005067526,0.00014071472],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2197836,0.0033781934,0.23160319,0.011852259,0.10410375,0.0005813199,0.0004137291,0.0022740935,0.051436953,0.00012442972,0.0052343747,0.36921412],"study_design_scores_gemma":[0.043124147,0.075388886,0.79326963,0.00094433216,0.06647445,0.0021404258,0.00021054769,0.0017644392,0.008943329,0.00012650312,0.007540035,0.00007334284],"about_ca_topic_score_codex":0.00051339046,"about_ca_topic_score_gemma":0.0022544917,"teacher_disagreement_score":0.00447598,"about_ca_system_score_codex":0.00034027555,"about_ca_system_score_gemma":0.0003840244,"threshold_uncertainty_score":0.023671508},"labels":[],"label_agreement":null},{"id":"W4396622704","doi":"10.1080/09546634.2024.2344589","title":"Rapid and sustained improvements in itch and quality of life with upadacitinib plus topical corticosteroids in adults and adolescents with atopic dermatitis: 52-week outcomes from the phase 3 AD Up study","year":2024,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Atopic dermatitis; Quality of life (healthcare); Janus kinase inhibitor; Dermatology; Internal medicine; Janus kinase","score_opus":0.041961038852902206,"score_gpt":0.3281564703111934,"score_spread":0.2861954314582912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396622704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581134,0.0023612427,0.00013982691,0.00008743229,0.000027925056,0.00067469716,0.00041953192,0.000017968234,0.00046006817],"genre_scores_gemma":[0.99588996,0.0013501194,0.00048739024,0.00031803528,0.00004728611,0.00083604234,0.0006484409,0.0000053267186,0.00041748653],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99955076,0.00020318017,0.00003330585,0.000054681706,0.0000651315,0.00009281132],"domain_scores_gemma":[0.9995421,0.00007465754,0.00014661228,0.000037200494,0.000040666073,0.00015888574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016106908,0.00058910216,0.0013578604,0.00018004121,0.00024857113,0.0006065585,0.00036347343,0.000601831,0.0014192687],"category_scores_gemma":[0.00068036915,0.00023779007,0.001399355,0.00024849127,0.00034746854,0.0003970982,0.0002993648,0.0014637337,0.00024363],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.601705,0.06858309,0.03645635,0.0021986153,0.0041294945,0.00034805562,0.00037001885,0.0018373939,0.0342425,0.00015119577,0.0039573265,0.24602094],"study_design_scores_gemma":[0.3316213,0.48987383,0.16492736,0.0001879105,0.0029513177,0.0004911084,0.00016869669,0.0014599545,0.0055798753,0.00012615751,0.002554764,0.000057773],"about_ca_topic_score_codex":0.00081737805,"about_ca_topic_score_gemma":0.0024718812,"teacher_disagreement_score":0.0016106908,"about_ca_system_score_codex":0.00040234195,"about_ca_system_score_gemma":0.0006394711,"threshold_uncertainty_score":0.008518279},"labels":[],"label_agreement":null},{"id":"W4396658262","doi":"10.1080/09546634.2024.2345739","title":"Patient preferences for treatment attributes in moderate-to-severe atopic dermatitis: a discrete choice experiment","year":2024,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Atopic dermatitis; Logistic regression; Adverse effect; Preference; Internal medicine; Relative risk; Physical therapy; Dermatology; Confidence interval","score_opus":0.049224193754316956,"score_gpt":0.3340321053102106,"score_spread":0.28480791155589363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396658262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980135,0.000024945359,0.00057876843,0.000104596584,0.000013855955,0.00061143044,0.000068767265,0.0000049336,0.000579116],"genre_scores_gemma":[0.99293387,0.000057921614,0.0038183252,0.0002905409,0.000020441803,0.0023546522,0.00007232459,0.000002136489,0.00044974306],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9948448,0.0038120276,0.00035309207,0.00027758663,0.00046889047,0.00024362994],"domain_scores_gemma":[0.97789043,0.017604712,0.0023135007,0.00064344093,0.00030850677,0.0012394201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009244527,0.0005804686,0.0006069006,0.0002461615,0.0005060927,0.0012534001,0.00044025655,0.0010196194,0.0059184455],"category_scores_gemma":[0.018018655,0.00036388604,0.0009500522,0.00025032135,0.0008227665,0.000855292,0.00059450686,0.0016973974,0.0005081885],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25886092,0.3353175,0.2095697,0.0018705537,0.0015642683,0.00055939,0.01110841,0.014160995,0.028635567,0.0049701585,0.0031912578,0.13019131],"study_design_scores_gemma":[0.09806862,0.52053165,0.21948507,0.00054581964,0.0014923168,0.0006783892,0.0063158125,0.10924434,0.01958101,0.0143719055,0.009179157,0.0005058657],"about_ca_topic_score_codex":0.00036250195,"about_ca_topic_score_gemma":0.00045597827,"teacher_disagreement_score":0.009244527,"about_ca_system_score_codex":0.00050994864,"about_ca_system_score_gemma":0.00085769966,"threshold_uncertainty_score":0.048890352},"labels":[],"label_agreement":null},{"id":"W4396869098","doi":"10.1080/09546634.2024.2324833","title":"Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials","year":2024,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"Eli Lilly and Company","keywords":"Medicine; Atopic dermatitis; Randomized controlled trial; Placebo; Dermatology; Clinical trial; Clinical efficacy; Internal medicine; Alternative medicine; Pathology","score_opus":0.10292422431291924,"score_gpt":0.39480289314384626,"score_spread":0.291878668830927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396869098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96771294,0.022853008,0.0011399382,0.0005106834,0.0001790547,0.004821811,0.0013914872,0.00010348531,0.0012874921],"genre_scores_gemma":[0.9789686,0.009576787,0.0023546568,0.0010812981,0.0002826357,0.005382612,0.0014590247,0.000027290276,0.0008669694],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974069,0.0015671491,0.0002745403,0.00027199314,0.00027746725,0.0002019426],"domain_scores_gemma":[0.9963025,0.0013161054,0.0011904753,0.0003262039,0.00033873614,0.0005260045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008037639,0.0012337303,0.0036377718,0.00038831535,0.0004812307,0.0012742977,0.0008504834,0.0014592446,0.0023542314],"category_scores_gemma":[0.0048624333,0.00054798985,0.0048017707,0.00056340673,0.00087909633,0.0008753113,0.0005688472,0.0020374903,0.0003436078],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.901926,0.009622615,0.012207694,0.0033495768,0.011757577,0.00010987239,0.00022183447,0.0008287064,0.0061617843,0.00010687411,0.0013480912,0.052359283],"study_design_scores_gemma":[0.8189424,0.14729542,0.023564493,0.00028375792,0.0062323324,0.000178869,0.00008662417,0.00041677264,0.0010951324,0.00019441394,0.001675269,0.000034491168],"about_ca_topic_score_codex":0.0006119722,"about_ca_topic_score_gemma":0.002340088,"teacher_disagreement_score":0.008037639,"about_ca_system_score_codex":0.0006956072,"about_ca_system_score_gemma":0.0013850604,"threshold_uncertainty_score":0.04250765},"labels":[],"label_agreement":null},{"id":"W4396928451","doi":"10.1080/09546634.2024.2349658","title":"Comparative analysis of persistence and remission with guselkumab <i>versus</i> secukinumab and ixekizumab in the United States","year":2024,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Biotech","keywords":"Secukinumab; Ixekizumab; Medicine; Persistence (discontinuity); Dermatology; Immunology; Psoriasis; Psoriatic arthritis","score_opus":0.051451101065958495,"score_gpt":0.28894458342242774,"score_spread":0.23749348235646925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396928451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99791974,0.0012807805,0.000055985154,0.00006756113,0.000007563887,0.000008207561,0.0004023037,0.0000026336745,0.0002553373],"genre_scores_gemma":[0.9991371,0.00025691555,0.000034251196,0.000050836334,0.0000109581815,0.0000079450665,0.00045693462,0.0000016799756,0.000043411932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978897,0.0009544007,0.00023291967,0.00042644682,0.00031380064,0.00018271251],"domain_scores_gemma":[0.99342597,0.002012737,0.003389157,0.00027329256,0.0003290143,0.0005698981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031350637,0.00015227502,0.0005433702,0.00060658134,0.00019091126,0.0006884522,0.00029883924,0.00039141497,0.0010861813],"category_scores_gemma":[0.0045324573,0.00016301984,0.0010800868,0.0009018325,0.00031259854,0.00046288167,0.0004465926,0.0005045725,0.00010082143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017241243,0.00022836863,0.9651496,0.00017232432,0.002260343,0.000068781155,0.00014160635,0.00028020306,0.00072297384,0.00009464104,0.0005492764,0.013090672],"study_design_scores_gemma":[0.0004782548,0.0036555731,0.9931531,0.000046941732,0.0009844905,0.00020458868,0.00017759622,0.00040147122,0.00025965538,0.000052520674,0.0005764212,0.000009415127],"about_ca_topic_score_codex":0.0030591353,"about_ca_topic_score_gemma":0.0035295712,"teacher_disagreement_score":0.0031350637,"about_ca_system_score_codex":0.0005161087,"about_ca_system_score_gemma":0.00048795613,"threshold_uncertainty_score":0.016580045},"labels":[],"label_agreement":null},{"id":"W4399034169","doi":"10.1080/09546634.2024.2350227","title":"Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO)","year":2024,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Medicine; Plaque psoriasis; Psoriasis; Dermatology; Psoriasis Area and Severity Index","score_opus":0.02965685294977767,"score_gpt":0.28558827444117285,"score_spread":0.2559314214913952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399034169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99885607,0.00058402267,0.000081494545,0.000044712557,0.0000050725453,0.000007213543,0.00017419773,0.0000025776915,0.00024464537],"genre_scores_gemma":[0.9995715,0.00006087875,0.00004479398,0.000016262416,0.000010585519,0.000007388727,0.00021249377,0.0000016250518,0.000074438125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978364,0.0011425731,0.00020265362,0.000365585,0.00027405698,0.00017872338],"domain_scores_gemma":[0.99029326,0.0039956435,0.0038307582,0.00055815495,0.0003708289,0.0009512713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003334288,0.00022015249,0.00058178155,0.0004485073,0.00021793119,0.0005381192,0.00032739947,0.00058936805,0.0015952477],"category_scores_gemma":[0.006761302,0.00017248043,0.0007058935,0.00044144268,0.00027006122,0.00047245325,0.00039268646,0.0010407735,0.00017472816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006037557,0.00015509891,0.990294,0.000039127804,0.0003321508,0.000040438095,0.0000743026,0.00016187847,0.00034098813,0.00001915131,0.000083453146,0.002421889],"study_design_scores_gemma":[0.00012804143,0.0010461899,0.9979662,0.0000068889467,0.000076525605,0.00014119364,0.000067093104,0.00039883095,0.000042383348,0.000024847925,0.00009575349,0.000006023115],"about_ca_topic_score_codex":0.0007357821,"about_ca_topic_score_gemma":0.0007602561,"teacher_disagreement_score":0.003334288,"about_ca_system_score_codex":0.00015903727,"about_ca_system_score_gemma":0.00019730501,"threshold_uncertainty_score":0.017633617},"labels":[],"label_agreement":null},{"id":"W4400174824","doi":"10.1080/09546634.2024.2371045","title":"Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials","year":2024,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Medicine; Placebo; Psoriasis; Apremilast; Plaque psoriasis; Onset of action; Internal medicine; Clinical trial; Randomized controlled trial; Gastroenterology; Dermatology; Pathology","score_opus":0.08820321456382156,"score_gpt":0.3608091798270552,"score_spread":0.2726059652632336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400174824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96549803,0.025764786,0.00069379807,0.0005805126,0.00012750637,0.0016496823,0.0009083287,0.00016162926,0.004615703],"genre_scores_gemma":[0.99103045,0.004386267,0.00089868746,0.0004347715,0.00011485018,0.0010094712,0.0009163766,0.000018221952,0.0011908399],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990344,0.00055770983,0.000059112404,0.00011809348,0.00010572302,0.00012503788],"domain_scores_gemma":[0.9990976,0.00021844801,0.0003520155,0.000054531338,0.000080417274,0.00019700929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026047025,0.0006988019,0.0014395132,0.00026958116,0.0003647604,0.00088370155,0.00050837913,0.0007871737,0.0023009924],"category_scores_gemma":[0.0014675697,0.00022404843,0.001359465,0.0003024839,0.00032071993,0.0005280423,0.00026410437,0.0016538745,0.00033720394],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64502907,0.011814519,0.012053819,0.0044264216,0.004491204,0.00025137412,0.00030651325,0.0036561436,0.037843626,0.0005276906,0.007640261,0.27195936],"study_design_scores_gemma":[0.59345955,0.2976166,0.07166254,0.0004474509,0.0033733263,0.0014500265,0.00013142887,0.0028344637,0.013658979,0.0008870405,0.014385701,0.00009291765],"about_ca_topic_score_codex":0.00049299747,"about_ca_topic_score_gemma":0.0017365275,"teacher_disagreement_score":0.0026047025,"about_ca_system_score_codex":0.00073451543,"about_ca_system_score_gemma":0.00081812416,"threshold_uncertainty_score":0.01377517},"labels":[],"label_agreement":null},{"id":"W4403287791","doi":"10.1080/09546634.2024.2414048","title":"A systematic review of recent randomized controlled trials for palmoplantar pustulosis","year":2024,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research; McMaster University","funders":"","keywords":"Palmoplantar pustulosis; Medicine; Randomized controlled trial; Dermatology; Quality of life (healthcare); Incidence (geometry); Psoriasis; Intensive care medicine; Surgery","score_opus":0.13774116053334678,"score_gpt":0.38436744412217355,"score_spread":0.24662628358882677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403287791","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010654378,0.9956251,0.00036121372,0.00032680604,0.00025284558,0.0009897398,0.0008139918,0.000021738804,0.0005431839],"genre_scores_gemma":[0.021461204,0.9721771,0.0015839296,0.0014507209,0.00017435967,0.0020903414,0.00073770987,0.000021163969,0.0003035338],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9885444,0.004664376,0.0042495555,0.00092194707,0.0013724093,0.0002472432],"domain_scores_gemma":[0.97566944,0.016510861,0.0050955513,0.00050254364,0.0019670068,0.0002544614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012486812,0.0018836709,0.01208081,0.006055665,0.0007571042,0.0027367675,0.0021260423,0.0019245885,0.011256103],"category_scores_gemma":[0.044295836,0.0010866745,0.0126127815,0.006664384,0.0009337202,0.002154769,0.0013268756,0.0017061408,0.00075504684],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010729578,0.000022306298,0.00034741394,0.9423422,0.028530436,0.00005962284,0.000051500934,0.000089082605,0.00015357461,0.00019440793,0.001294881,0.025841575],"study_design_scores_gemma":[0.0032641366,0.0007000112,0.0036456103,0.63850313,0.32824564,0.00027076702,0.00015257699,0.00012122494,0.0003178098,0.00071524736,0.023998372,0.00006538741],"about_ca_topic_score_codex":0.005199641,"about_ca_topic_score_gemma":0.014697203,"teacher_disagreement_score":0.012486812,"about_ca_system_score_codex":0.0035803213,"about_ca_system_score_gemma":0.008283705,"threshold_uncertainty_score":0.06603736},"labels":[],"label_agreement":null},{"id":"W4404014696","doi":"10.1080/09546634.2024.2422909","title":"Complete responses and SALT zero scores in alopecia areata: not the same","year":2024,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Community Based Research Centre; University of British Columbia","funders":"","keywords":"Alopecia areata; Medicine; Dermatology","score_opus":0.061284090668735275,"score_gpt":0.3228784799423942,"score_spread":0.26159438927365897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404014696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9579046,0.003579733,0.0014198343,0.0016432031,0.00041347565,0.00014592902,0.0014974196,0.00008707457,0.03330876],"genre_scores_gemma":[0.9977464,0.00017642645,0.00013688912,0.00022618652,0.00008789869,0.00001795317,0.00030258356,0.00001608873,0.0012895907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99612856,0.001231878,0.00036151375,0.0005147151,0.0012410509,0.00052235526],"domain_scores_gemma":[0.98908126,0.00473533,0.0023401126,0.00083446834,0.0018174169,0.0011914239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028394905,0.0004673022,0.0011980993,0.0009443167,0.00052836654,0.0010644703,0.0009082555,0.0014894812,0.008700142],"category_scores_gemma":[0.012452684,0.00024415506,0.0013834658,0.0007298729,0.0008394171,0.0020706258,0.0009012488,0.001823151,0.0020250808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00584605,0.00037677417,0.9456863,0.00023964922,0.001004576,0.0012941217,0.0006413877,0.00036748347,0.0042159217,0.0007426723,0.003322898,0.036262266],"study_design_scores_gemma":[0.00012297613,0.0005539378,0.9931617,0.000050800474,0.00025557398,0.0021158417,0.0005503682,0.00046501312,0.00046224677,0.00076583953,0.0014645655,0.000031063893],"about_ca_topic_score_codex":0.0013332075,"about_ca_topic_score_gemma":0.0019044289,"teacher_disagreement_score":0.008700142,"about_ca_system_score_codex":0.00052283896,"about_ca_system_score_gemma":0.00034122655,"threshold_uncertainty_score":0.029104829},"labels":[],"label_agreement":null},{"id":"W4405252165","doi":"10.1080/09546634.2024.2428729","title":"Real-world evidence on the benefits of optimal itch relief and skin clearance in atopic dermatitis management: a study from the TARGET-DERM AD registry","year":2024,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"","keywords":"Medicine; Atopic dermatitis; Dermatology","score_opus":0.03976122395500714,"score_gpt":0.31264000543240145,"score_spread":0.2728787814773943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405252165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93517816,0.05086303,0.0021103753,0.0016845939,0.0001618378,0.00041954918,0.0052894177,0.000037646987,0.0042552464],"genre_scores_gemma":[0.9922064,0.0040989113,0.0009814788,0.00053796713,0.00016257762,0.00022374984,0.0016111156,0.0000119623055,0.00016577217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.967967,0.024861649,0.002624982,0.0021346011,0.0019608592,0.00045089418],"domain_scores_gemma":[0.9118043,0.05705201,0.022493336,0.0054923915,0.0021561172,0.0010018331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03165836,0.00044069593,0.0015579944,0.0008105743,0.00044336932,0.0021061131,0.001137521,0.0009341421,0.004207655],"category_scores_gemma":[0.06457741,0.00039000684,0.004587255,0.0020791206,0.0008952347,0.0017152465,0.0011572421,0.0015565315,0.00044942572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055400185,0.0027001824,0.80057967,0.007841162,0.023442267,0.00020178995,0.00059101364,0.0048563275,0.00032698127,0.0018774171,0.0038617752,0.09832124],"study_design_scores_gemma":[0.010783679,0.0192596,0.91751796,0.0037290414,0.02307928,0.0007326878,0.00085152785,0.0076956796,0.00069043646,0.002008459,0.013495001,0.00015667155],"about_ca_topic_score_codex":0.0019638322,"about_ca_topic_score_gemma":0.0024622092,"teacher_disagreement_score":0.03165836,"about_ca_system_score_codex":0.0011424049,"about_ca_system_score_gemma":0.0011198593,"threshold_uncertainty_score":0.16742742},"labels":[],"label_agreement":null},{"id":"W4407358806","doi":"10.1080/09546634.2025.2464107","title":"Oral roflumilast for psoriasis: a real-world 24-week prospective cohort study","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Roflumilast; Psoriasis; Prospective cohort study; Cohort; Cohort study; Dermatology; Internal medicine; COPD","score_opus":0.03453545310000239,"score_gpt":0.30395596781091644,"score_spread":0.26942051471091405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407358806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99879897,0.00034946183,0.00012786336,0.000028026632,0.000008338048,0.00006872091,0.00042312275,0.000003896733,0.00019159487],"genre_scores_gemma":[0.9985619,0.00024842718,0.00019535866,0.000049355607,0.000027374424,0.000057111552,0.00064635347,0.0000038444177,0.00021018233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912065,0.00033567045,0.00006904969,0.0002179208,0.00013345404,0.00012323368],"domain_scores_gemma":[0.99841607,0.0002955952,0.0005740333,0.00025875852,0.00017486385,0.00028065054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015765423,0.00047215898,0.0006290612,0.0004789417,0.00052925217,0.0007923665,0.0003395869,0.00065554044,0.0017846394],"category_scores_gemma":[0.0018429435,0.00041846506,0.0011072034,0.00071490393,0.00024552768,0.0004892092,0.00036690492,0.0006643068,0.0004981979],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009029732,0.001750223,0.9799954,0.0001251911,0.0010456782,0.0005491097,0.00022695874,0.00009933378,0.0011144644,0.000035033667,0.00047467565,0.0055540767],"study_design_scores_gemma":[0.0010153669,0.0043327976,0.9917339,0.00002657326,0.0005974415,0.00083252287,0.00024423873,0.00036417326,0.00015788,0.000024689265,0.00064544793,0.000024928342],"about_ca_topic_score_codex":0.0021242313,"about_ca_topic_score_gemma":0.0022303192,"teacher_disagreement_score":0.0021242313,"about_ca_system_score_codex":0.0002901047,"about_ca_system_score_gemma":0.0004269032,"threshold_uncertainty_score":0.0083376765},"labels":[],"label_agreement":null},{"id":"W4407947855","doi":"10.1080/09546634.2025.2471451","title":"Epidemiology, genetics and management of vitiligo in the USA: an All of Us investigation","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Vitiligo; Medicine; Epidemiology; Disease management; Gerontology; Genetics; Dermatology; Alternative medicine; Pathology; Health management system; Biology","score_opus":0.06927202649355424,"score_gpt":0.3667290324503358,"score_spread":0.29745700595678154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407947855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427336,0.001974483,0.0001469453,0.0011291218,0.000012635101,0.000012239424,0.00085738074,0.0000058018427,0.0015880064],"genre_scores_gemma":[0.9978648,0.0012386431,0.00015792735,0.00026562763,0.000020053714,0.000007660695,0.00032315587,0.0000019405156,0.00012032011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973327,0.00007656277,0.00003000747,0.000053125103,0.00006444557,0.000042523876],"domain_scores_gemma":[0.9989937,0.00015187052,0.0004979828,0.000044778077,0.00013654843,0.00017500874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035281698,0.00009169034,0.00013144352,0.0008135073,0.00037148548,0.0004235681,0.00021882278,0.00024164576,0.001083644],"category_scores_gemma":[0.0014306989,0.000096715514,0.00015820721,0.00170104,0.0001846014,0.0002800115,0.00034993383,0.00032619064,0.00007877919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011549428,0.00003025331,0.9942127,0.000012764864,0.00001690252,0.000046311605,0.00009001049,0.0000151486065,0.00009156565,0.00005011095,0.0005546676,0.0048680305],"study_design_scores_gemma":[0.0000015047351,0.000020889314,0.9983278,0.000032786684,0.000016425836,0.00034200517,0.00035548108,0.000101887344,0.000030148305,0.00005345151,0.000715772,0.0000019324184],"about_ca_topic_score_codex":0.029686414,"about_ca_topic_score_gemma":0.045080632,"teacher_disagreement_score":0.029686414,"about_ca_system_score_codex":0.0005368612,"about_ca_system_score_gemma":0.00077323604,"threshold_uncertainty_score":0.059027255},"labels":[],"label_agreement":null},{"id":"W4408516286","doi":"10.1080/09546634.2025.2479126","title":"Topical delgocitinib for the treatment of chronic hand eczema","year":2025,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Dermatology; Hand eczema; Allergy; Contact dermatitis; Immunology","score_opus":0.08650470726124279,"score_gpt":0.4029417386772591,"score_spread":0.3164370314160163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408516286","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012986946,0.99603736,0.00006195486,0.00035036108,0.00010135341,0.000026794582,0.00012727291,0.000006690467,0.0019894184],"genre_scores_gemma":[0.029624645,0.968088,0.0003600953,0.0006746754,0.00024728038,0.000044731856,0.00022675563,0.0000033248054,0.0007304559],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996377,0.00010948193,0.00008602757,0.000040322808,0.000105591826,0.000020845413],"domain_scores_gemma":[0.9993055,0.00037912893,0.00020869561,0.000010074364,0.00007050248,0.000026114218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005256211,0.00019784435,0.00086676236,0.0017448639,0.00022525497,0.0007232205,0.0002884565,0.00049681787,0.005846149],"category_scores_gemma":[0.0013385983,0.00008206499,0.000695313,0.001456452,0.00021399994,0.0004907348,0.0002672381,0.00047538077,0.0006435329],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006357006,0.0000665984,0.00079602556,0.18570016,0.000544274,0.00041294502,0.00011773967,0.00014639167,0.0027708728,0.0010245021,0.01688641,0.79089826],"study_design_scores_gemma":[0.0010652723,0.0010921799,0.011738749,0.16701272,0.006087538,0.007375776,0.0004135209,0.00040002624,0.0035072498,0.0014933541,0.7997525,0.00006116973],"about_ca_topic_score_codex":0.00094345654,"about_ca_topic_score_gemma":0.0037663728,"teacher_disagreement_score":0.005846149,"about_ca_system_score_codex":0.00045061015,"about_ca_system_score_gemma":0.0009939593,"threshold_uncertainty_score":0.019557297},"labels":[],"label_agreement":null},{"id":"W4408914407","doi":"10.1080/09546634.2025.2482009","title":"The impact of cannabis use on local anesthetic dosing during hair restoration surgery: a case report, proposed mechanisms, and clinical recommendations","year":2025,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Dosing; Cannabis; Local anesthetic; Anesthetic; Anesthesia; Surgery; Intensive care medicine; Psychiatry; Pharmacology","score_opus":0.10653375380628648,"score_gpt":0.443578762879763,"score_spread":0.3370450090734765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408914407","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051139966,0.9782824,0.0019126227,0.006185122,0.0007883432,0.000045907516,0.000074151525,0.00005053064,0.007546905],"genre_scores_gemma":[0.06459402,0.9241079,0.0025832765,0.0030861532,0.0025322423,0.00003744316,0.00013278412,0.000013545814,0.0029126063],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99949396,0.00009374692,0.00011017251,0.000095346804,0.00013386278,0.0000729355],"domain_scores_gemma":[0.9992236,0.00037143254,0.00018940601,0.000029792165,0.00012372533,0.000061965075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005222129,0.0010592327,0.0009358074,0.0027870995,0.00091489387,0.0015486616,0.001107961,0.0028531922,0.0032243165],"category_scores_gemma":[0.0017025304,0.00035432083,0.0010222903,0.0014529949,0.0011837662,0.0023412025,0.0007322382,0.002259774,0.0010299585],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016200353,0.00021587423,0.01028117,0.015443407,0.0002592552,0.3078801,0.0009267938,0.00087534235,0.0044332277,0.010730494,0.031015515,0.6177769],"study_design_scores_gemma":[0.000039630468,0.00008614978,0.0047747702,0.0067127952,0.00033942296,0.7679865,0.0011766063,0.00055821677,0.0017738198,0.008976158,0.20748785,0.00008811542],"about_ca_topic_score_codex":0.0024767842,"about_ca_topic_score_gemma":0.0041421996,"teacher_disagreement_score":0.0032243165,"about_ca_system_score_codex":0.00093393517,"about_ca_system_score_gemma":0.0018531132,"threshold_uncertainty_score":0.010786414},"labels":[],"label_agreement":null},{"id":"W4411022782","doi":"10.1080/09546634.2025.2513054","title":"A network meta-analysis study of monotherapies for hidradenitis suppurativa: analyses of the current evidence base","year":2025,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); Women's College Hospital; University of Toronto","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Base (topology); Meta-analysis; Internal medicine; Disease","score_opus":0.5825344248372164,"score_gpt":0.5209130035748681,"score_spread":0.061621421262348264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411022782","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026849754,0.96034193,0.0069200513,0.00083740725,0.0007074187,0.0006644279,0.002302263,0.00016122809,0.001215512],"genre_scores_gemma":[0.78430355,0.19494015,0.0114522735,0.0019068354,0.000666145,0.0023261101,0.003181378,0.00021581544,0.0010077058],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.95616066,0.03326653,0.0042756638,0.003811259,0.00189801,0.00058786006],"domain_scores_gemma":[0.92193395,0.067436256,0.005143784,0.0029448823,0.0018987171,0.00064237847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.040615402,0.0039922367,0.018094294,0.006171299,0.0006650051,0.004054827,0.0026071824,0.0025834744,0.006011839],"category_scores_gemma":[0.0760918,0.0016030731,0.05539431,0.0059023583,0.0007497465,0.0023529597,0.0021258683,0.0033669616,0.00050798943],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003174895,0.00001747064,0.0039602667,0.026149407,0.96162623,0.000071035,0.000022522672,0.0011017204,0.0000948069,0.00014530688,0.0003282015,0.0033081758],"study_design_scores_gemma":[0.0008576117,0.0001806772,0.0028855496,0.0018308613,0.99187815,0.00004723367,0.000015895008,0.0009975849,0.000056359306,0.0005159013,0.0007179339,0.000016291247],"about_ca_topic_score_codex":0.0062588747,"about_ca_topic_score_gemma":0.006764024,"teacher_disagreement_score":0.040615402,"about_ca_system_score_codex":0.0020466978,"about_ca_system_score_gemma":0.0019480416,"threshold_uncertainty_score":0.21479732},"labels":[],"label_agreement":null},{"id":"W4411026382","doi":"10.1080/09546634.2025.2504655","title":"Fractional microneedle radiofrequency with the application of vitamin C, E, and ferulic acid serum for neck skin rejuvenation: a prospective, double-blinded, split-neck, placebo-controlled trial","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; University of British Columbia","funders":"Yonsei University","keywords":"Medicine; Rejuvenation; Ferulic acid; Placebo; Double blinded; Vitamin C; Prospective cohort study; Surgery; Dermatology; Internal medicine; Pathology","score_opus":0.02463840288458526,"score_gpt":0.3330529627077151,"score_spread":0.3084145598231299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411026382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98689705,0.008863173,0.00056314206,0.00022423388,0.00033892776,0.0022179263,0.000282911,0.000048721682,0.0005640407],"genre_scores_gemma":[0.98804086,0.004573905,0.0017439048,0.00047935938,0.00039713088,0.0029587757,0.00027776958,0.000010331352,0.0015179937],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995223,0.00019199803,0.000058878464,0.000110193905,0.00005895572,0.000057686044],"domain_scores_gemma":[0.9994055,0.00017478659,0.00016236203,0.00004599832,0.00006538726,0.00014594806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015569193,0.00097347284,0.0026530633,0.00037826775,0.00038858844,0.0006948486,0.0006983698,0.0017479472,0.0034979957],"category_scores_gemma":[0.001141147,0.00047595453,0.0012084133,0.00030278973,0.00076414854,0.00064648356,0.00027502177,0.0012324536,0.000450854],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9623478,0.009930483,0.0003464959,0.0012975082,0.0007897265,0.000026274141,0.00003256656,0.00009437134,0.008869939,0.000045434284,0.00017446517,0.016044818],"study_design_scores_gemma":[0.8091082,0.18654868,0.0017139497,0.000060904666,0.00064931187,0.000036533198,0.000021655402,0.00016988876,0.0013086055,0.000037305548,0.00033455904,0.000010374652],"about_ca_topic_score_codex":0.0006762655,"about_ca_topic_score_gemma":0.0013647972,"teacher_disagreement_score":0.0034979957,"about_ca_system_score_codex":0.00042480303,"about_ca_system_score_gemma":0.00084485376,"threshold_uncertainty_score":0.0117019415},"labels":[],"label_agreement":null},{"id":"W4412063952","doi":"10.1080/09546634.2025.2526073","title":"Global onychomycosis management and the challenges of antifungal stewardship","year":2025,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Antifungal; Stewardship (theology); Intensive care medicine; Dermatology","score_opus":0.06682672204896437,"score_gpt":0.37040779014517705,"score_spread":0.30358106809621266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412063952","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07096957,0.50443923,0.0091574835,0.38304895,0.002543322,0.00014789855,0.00035731547,0.000260968,0.029075328],"genre_scores_gemma":[0.6340203,0.30235553,0.016845852,0.04253368,0.0017635085,0.00014306558,0.0003874788,0.00015229455,0.0017982665],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9844715,0.0072301743,0.0023353184,0.0013755014,0.0036606458,0.00092680426],"domain_scores_gemma":[0.96928555,0.011287112,0.0067742765,0.0015346052,0.007750531,0.0033680196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014103427,0.00043729378,0.00083184557,0.0016723219,0.0012525753,0.0062167686,0.0016295229,0.0018748323,0.0031240154],"category_scores_gemma":[0.029886374,0.00025605035,0.0006935552,0.0026458951,0.0033217852,0.006079337,0.005745952,0.0032681793,0.0004984862],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008761099,0.0001532687,0.050405685,0.013365671,0.0003115812,0.0023217949,0.017126217,0.0017268301,0.0019076474,0.023712961,0.07289943,0.8159814],"study_design_scores_gemma":[0.000068338064,0.0004662605,0.11278634,0.06278009,0.00052663503,0.009799564,0.063973196,0.0018808091,0.002563752,0.062783405,0.6821059,0.0002657326],"about_ca_topic_score_codex":0.0064163967,"about_ca_topic_score_gemma":0.0074054464,"teacher_disagreement_score":0.014103427,"about_ca_system_score_codex":0.0028790843,"about_ca_system_score_gemma":0.010383193,"threshold_uncertainty_score":0.07458693},"labels":[],"label_agreement":null},{"id":"W4412197636","doi":"10.1080/09546634.2025.2525287","title":"Efficacy of oral isotretinoin monotherapy compared to combination isotretinoin and topical clascoterone for severe acne vulgaris: a multi-center retrospective study","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; McMaster University","funders":"","keywords":"Medicine; Isotretinoin; Acne; Dermatology; Retrospective cohort study; Surgery","score_opus":0.03661990874853594,"score_gpt":0.3554664952659496,"score_spread":0.31884658651741365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412197636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99905294,0.00071080343,0.00003503665,0.0000065275835,0.0000026424575,0.000022479919,0.000055601096,8.1329756e-7,0.0001131257],"genre_scores_gemma":[0.99957603,0.00019117424,0.00005428342,0.000013967551,0.0000123239,0.000017498229,0.000099459314,7.9796024e-7,0.000034523535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982326,0.0006437701,0.00030015293,0.00041181783,0.00027624684,0.0001354903],"domain_scores_gemma":[0.99757177,0.00062951737,0.0011934035,0.00011967217,0.00020524705,0.0002804351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013693209,0.00034968337,0.0009568412,0.00083446945,0.00039803906,0.0005890996,0.00036862248,0.00053619867,0.0012820532],"category_scores_gemma":[0.001664712,0.000381591,0.0012073088,0.000970355,0.00037051426,0.00053974404,0.00034003588,0.00031618783,0.00023842507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019662236,0.00021330731,0.9947812,0.00006883448,0.00037484776,0.00028558294,0.00009412668,0.000027956545,0.00048398672,0.000006315134,0.000029296978,0.0016682174],"study_design_scores_gemma":[0.00025556947,0.0057261614,0.98979414,0.00003393544,0.000621552,0.0023489655,0.00038677582,0.00023693501,0.00025388866,0.000013309857,0.00031392084,0.000014854535],"about_ca_topic_score_codex":0.00076106936,"about_ca_topic_score_gemma":0.00087396835,"teacher_disagreement_score":0.0013693209,"about_ca_system_score_codex":0.00033995486,"about_ca_system_score_gemma":0.00032704227,"threshold_uncertainty_score":0.0072417855},"labels":[],"label_agreement":null},{"id":"W4412422999","doi":"10.1080/09546634.2025.2523373","title":"The hf-PGA is a valid and reliable measure of hand/foot psoriasis severity in adults: results from a phase 2b clinical trial","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research; Innovaderm (Canada)","funders":"","keywords":"Medicine; Psoriasis; Foot (prosody); Clinical trial; Physical therapy; Dermatology; Measure (data warehouse); Physical medicine and rehabilitation; Surgery; Internal medicine; Data mining","score_opus":0.06067050228900951,"score_gpt":0.34320144719193957,"score_spread":0.28253094490293007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412422999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98110574,0.0065950784,0.001985342,0.0009679545,0.00023809112,0.0047947327,0.0021259107,0.00014116365,0.0020459767],"genre_scores_gemma":[0.981326,0.0030558456,0.004443137,0.0020176538,0.00061231846,0.004527185,0.002650746,0.000039428145,0.0013277192],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971583,0.0018135837,0.00018240698,0.0002815342,0.00040441635,0.00015977149],"domain_scores_gemma":[0.9971687,0.0010102771,0.00087220577,0.00026922498,0.00028727835,0.00039235898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009290909,0.0010488909,0.0016052924,0.00036627936,0.00040671593,0.0008585296,0.0005517674,0.0014567496,0.0028865368],"category_scores_gemma":[0.0071378937,0.00037627778,0.0011045234,0.00042982286,0.0007961645,0.0010294047,0.00036290838,0.0021022884,0.0005641962],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8018151,0.027909504,0.020173136,0.0014545914,0.0037096203,0.00013292396,0.00031812963,0.0007583439,0.009716777,0.00025683636,0.003929154,0.12982595],"study_design_scores_gemma":[0.69535637,0.22398408,0.07244001,0.00015336115,0.0015232762,0.00025566958,0.000080324666,0.0009422379,0.001787252,0.00029073984,0.0031364288,0.00005030334],"about_ca_topic_score_codex":0.00047224973,"about_ca_topic_score_gemma":0.0010395908,"teacher_disagreement_score":0.009290909,"about_ca_system_score_codex":0.00032178732,"about_ca_system_score_gemma":0.0007736466,"threshold_uncertainty_score":0.049135566},"labels":[],"label_agreement":null},{"id":"W4412654198","doi":"10.1080/09546634.2025.2492188","title":"Lebrikizumab improves head/neck/face dermatitis and erythema and does not increase treatment-emergent adverse events of head/neck/face erythema in patients with moderate-to-severe atopic dermatitis","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; University of British Columbia","funders":"Dermira; Eli Lilly and Company","keywords":"Medicine; Erythema; Dermatology; Atopic dermatitis; Adverse effect; Eczema Area and Severity Index; Placebo; Head and neck; Internal medicine; Surgery; Pathology","score_opus":0.011213966246588164,"score_gpt":0.2672021434311173,"score_spread":0.25598817718452915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412654198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99160355,0.0064471504,0.00021340724,0.00016271826,0.000056968627,0.00019911671,0.000124562,0.000042488624,0.0011500441],"genre_scores_gemma":[0.997855,0.0010279668,0.00030704978,0.00018777812,0.00007505428,0.00007158384,0.000117321775,0.0000046768046,0.00035358948],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997285,0.00011592352,0.000032342195,0.000033618853,0.000052734256,0.000036921156],"domain_scores_gemma":[0.9995253,0.00013634138,0.00016282142,0.000038558133,0.000055290744,0.000081721984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010577872,0.0002665442,0.00092208403,0.00014093885,0.00014556412,0.00028462187,0.0002278492,0.00030603382,0.0013765077],"category_scores_gemma":[0.0010586496,0.00011784185,0.0007417391,0.00014042789,0.00018057901,0.00031829558,0.00012862585,0.00087138766,0.00021566689],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29029423,0.02002086,0.06548609,0.0035796498,0.0025157102,0.00042235234,0.00032154477,0.0013112427,0.07159279,0.00013305213,0.0037294955,0.540593],"study_design_scores_gemma":[0.1274731,0.47292823,0.3625791,0.00030163175,0.002437894,0.0019022985,0.00029397462,0.002620557,0.02181908,0.00015801252,0.0074393563,0.000046726058],"about_ca_topic_score_codex":0.00024522777,"about_ca_topic_score_gemma":0.0007688408,"teacher_disagreement_score":0.0013765077,"about_ca_system_score_codex":0.00024744062,"about_ca_system_score_gemma":0.00034254268,"threshold_uncertainty_score":0.005594194},"labels":[],"label_agreement":null},{"id":"W4413113011","doi":"10.1080/09546634.2025.2541970","title":"Effectiveness of double-layer artificial dermis repair material combined with autologous skin patch in repairing deep skin and soft tissue defects: a retrospective study","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Wound Healing and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dermis; Medicine; Artificial skin; Skin grafting; Soft tissue; Surgery; Skin repair; Wound healing; Pathology","score_opus":0.01982860065848656,"score_gpt":0.317454431385622,"score_spread":0.29762583072713544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413113011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555004,0.0035389361,0.0003468371,0.000010341399,0.000008095333,0.00003279395,0.000049295606,0.0000036319418,0.00046004835],"genre_scores_gemma":[0.99842596,0.0010210656,0.00024209847,0.000021589422,0.000023047842,0.000020929778,0.000081145125,0.0000027976478,0.00016125574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999464,0.00011903817,0.00012876226,0.00011093165,0.000110188106,0.00006710159],"domain_scores_gemma":[0.9988814,0.00030065095,0.0005016153,0.0000886722,0.000099947676,0.00012767519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005316972,0.00028959374,0.0005789326,0.001204926,0.00034741985,0.00041602622,0.00022798026,0.00043110354,0.0012170033],"category_scores_gemma":[0.0010529953,0.0002620159,0.0010137878,0.0008148813,0.0003478913,0.00045865952,0.0002679724,0.00028661898,0.00025070994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015911671,0.0006895189,0.9562444,0.0003954619,0.00047919076,0.0071004867,0.0002783465,0.00017022788,0.005537707,0.000061757084,0.00013416883,0.027317649],"study_design_scores_gemma":[0.0001660743,0.01284736,0.8754057,0.00012995205,0.0012929878,0.09667918,0.0012481199,0.0006264973,0.00678815,0.000065045184,0.004695832,0.00005503823],"about_ca_topic_score_codex":0.0002418705,"about_ca_topic_score_gemma":0.00028011936,"teacher_disagreement_score":0.0012170033,"about_ca_system_score_codex":0.00017788094,"about_ca_system_score_gemma":0.00019730238,"threshold_uncertainty_score":0.0040712953},"labels":[],"label_agreement":null},{"id":"W4414289720","doi":"10.1080/09546634.2023.2253942","title":"TNF-alpha inhibitor therapy for granuloma annulare","year":2025,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Skin Diseases and Diabetes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Etanercept; Granuloma annulare; Infliximab; Granuloma; Immunopathology","score_opus":0.07403467192425874,"score_gpt":0.3996113485249058,"score_spread":0.3255766766006471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414289720","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001120096,0.9994259,0.000034005465,0.00006011645,0.00007245013,0.0000026747366,0.000004517772,0.000002743326,0.00028565552],"genre_scores_gemma":[0.002013916,0.99731135,0.00008620142,0.00016360651,0.00017403603,0.0000053446015,0.000017890832,0.0000010215216,0.00022658198],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997805,0.00005249764,0.000044147702,0.000034161454,0.00007139876,0.000017332253],"domain_scores_gemma":[0.99972206,0.00014206271,0.000077153854,0.000006177682,0.000033268127,0.000019311103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004632412,0.00062483014,0.0013556709,0.0019837748,0.00022164409,0.0005105676,0.00065781386,0.00078576023,0.002493023],"category_scores_gemma":[0.00066283514,0.00017211013,0.00065134553,0.0011280408,0.0002887011,0.0005722967,0.00031116445,0.0010388829,0.0010377478],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020494334,0.00009672459,0.0003720687,0.04371744,0.00028555124,0.0009647599,0.000049996434,0.00021035658,0.0010755707,0.00081694196,0.027280211,0.9249255],"study_design_scores_gemma":[0.00033030615,0.0005178536,0.0038852175,0.036222447,0.0014717273,0.031636517,0.000149891,0.00031543442,0.0018145206,0.0014783035,0.92213005,0.000047583388],"about_ca_topic_score_codex":0.0005764087,"about_ca_topic_score_gemma":0.0010300276,"teacher_disagreement_score":0.002493023,"about_ca_system_score_codex":0.0003119269,"about_ca_system_score_gemma":0.00050611584,"threshold_uncertainty_score":0.008340001},"labels":[],"label_agreement":null},{"id":"W4415040496","doi":"10.1080/09546634.2025.2555984","title":"Assessment of vitiligo in clinical practice: a cross-sectional survey among experts","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital; SKiN Health","funders":"LEO Pharma; Incyte; Les Laboratories Pierre Fabre; Sanofi; Vlaamse regering; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Vitiligo; Clinical Practice; MEDLINE; Clinical trial; Quality of life (healthcare); Depigmentation","score_opus":0.051481684810737074,"score_gpt":0.4677310750810004,"score_spread":0.41624939027026336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415040496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99925417,0.00009159793,0.00009613306,0.0001007907,0.000002503989,0.0000336756,0.00007834689,0.0000013909299,0.00034140164],"genre_scores_gemma":[0.9995121,0.000098685305,0.00015029685,0.000074777636,0.0000029108476,0.000032099782,0.000060198396,6.427696e-7,0.00006828193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997271,0.001154029,0.00037567466,0.00031378827,0.00056393835,0.00032150446],"domain_scores_gemma":[0.99337786,0.0025120534,0.0021604449,0.00024536767,0.00084263703,0.0008615693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047726715,0.00012640031,0.00032013495,0.0010976137,0.00045746,0.00078242895,0.00023977578,0.0006661006,0.0013421994],"category_scores_gemma":[0.008937135,0.00021565313,0.00024003218,0.00082851993,0.0004582192,0.00076930504,0.00093065604,0.00048602067,0.00024896936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027813705,0.00010176333,0.9938611,0.000044498596,0.000015808344,0.00006987258,0.0024269833,0.000034466346,0.00018163436,0.00002414833,0.0001617961,0.00305006],"study_design_scores_gemma":[0.000007803799,0.0003931487,0.98697144,0.000056170695,0.000012226974,0.00041636007,0.01087247,0.00029868115,0.000094563635,0.000039072394,0.0008271165,0.000010896987],"about_ca_topic_score_codex":0.001745335,"about_ca_topic_score_gemma":0.0018804945,"teacher_disagreement_score":0.0047726715,"about_ca_system_score_codex":0.00047786866,"about_ca_system_score_gemma":0.00057265494,"threshold_uncertainty_score":0.02524066},"labels":[],"label_agreement":null},{"id":"W4415356641","doi":"10.1080/09546634.2025.2572645","title":"Treating onychomycosis in diabetic patients: risk, therapy, and topical opportunity","year":2025,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Comorbidity; Diabetes mellitus; Population; MEDLINE; Disease management; Disease","score_opus":0.08496539880020217,"score_gpt":0.3667495301076229,"score_spread":0.28178413130742075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415356641","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018688941,0.95012987,0.0018158653,0.019314643,0.0010076987,0.000053121155,0.000050776813,0.00003833496,0.008900724],"genre_scores_gemma":[0.12215355,0.8642617,0.0045721745,0.0051606502,0.0021459833,0.000067597786,0.000092511684,0.0000093164335,0.0015365168],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99944884,0.0002074337,0.000081818434,0.000031664647,0.00018419087,0.000045955323],"domain_scores_gemma":[0.9993986,0.00023708053,0.00017004766,0.000011528609,0.00010777225,0.000074927186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078666524,0.00024822511,0.00056497916,0.00044666458,0.00037935292,0.0009610924,0.0002658706,0.0007999525,0.0009599454],"category_scores_gemma":[0.0022778278,0.00009923351,0.00036495418,0.00046944123,0.00025600495,0.0006168725,0.00045175353,0.001350787,0.00021562332],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041180683,0.00031790356,0.020946259,0.0075126807,0.00025873046,0.0035755252,0.0004329599,0.00056402956,0.0026361968,0.0029397197,0.029231986,0.9311723],"study_design_scores_gemma":[0.00048248374,0.0017233703,0.102356926,0.039113957,0.0014894498,0.07604957,0.0041216766,0.002203236,0.0043885503,0.01565003,0.75226,0.00016070768],"about_ca_topic_score_codex":0.00080042257,"about_ca_topic_score_gemma":0.0017665683,"teacher_disagreement_score":0.0009610924,"about_ca_system_score_codex":0.00034959486,"about_ca_system_score_gemma":0.0011561876,"threshold_uncertainty_score":0.0041603446},"labels":[],"label_agreement":null},{"id":"W4415691157","doi":"10.1080/09546634.2025.2572655","title":"A CollaboraTive Initiative of worldwide Vitiligo Experts and patients to define vitiligo activity (ACTIVE): study protocol","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Vlaamse regering; Universiteit Gent; Pfizer","keywords":"Vitiligo; Protocol (science); Comparability; Clinical trial; Consistency (knowledge bases); Disease; Quality of life (healthcare)","score_opus":0.013716785651510995,"score_gpt":0.3356993190594204,"score_spread":0.3219825334079094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415691157","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023391885,0.00017874288,0.004537116,0.0005488282,0.00018282136,0.9886516,0.0011330971,0.000051807725,0.002376753],"genre_scores_gemma":[0.001816851,0.00010568656,0.006149148,0.00028466008,0.00003082446,0.99071306,0.0003874507,0.0000081247235,0.0005042101],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9414907,0.044412162,0.006066836,0.0029470092,0.002900812,0.0021824825],"domain_scores_gemma":[0.9501275,0.018203046,0.0066923965,0.0068820207,0.012394567,0.0057004513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.11758868,0.0025369604,0.0028968265,0.0029815375,0.004899109,0.0040142643,0.004095716,0.0049820454,0.047796182],"category_scores_gemma":[0.06320587,0.0023409731,0.0028619599,0.0025312281,0.002934017,0.004514882,0.0063586575,0.007039383,0.01284629],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14403388,0.028859407,0.01810812,0.063980386,0.0012994927,0.0026658075,0.027022913,0.004923656,0.009344451,0.051355116,0.27713385,0.37127295],"study_design_scores_gemma":[0.14233863,0.019190807,0.05069603,0.035617698,0.0010118034,0.0011208399,0.012704396,0.0053589316,0.005194015,0.022567492,0.70345503,0.00074432587],"about_ca_topic_score_codex":0.0027318865,"about_ca_topic_score_gemma":0.0050511886,"teacher_disagreement_score":0.11758868,"about_ca_system_score_codex":0.0065877773,"about_ca_system_score_gemma":0.048042495,"threshold_uncertainty_score":0.62187576},"labels":[],"label_agreement":null},{"id":"W4415851239","doi":"10.1080/09546634.2025.2580374","title":"Comparative efficacy of omalizumab, dupilumab, and remibrutinib in chronic spontaneous urticaria: a network meta-analysis of randomized control trials","year":2025,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Western University; McMaster University","funders":"","keywords":"Omalizumab; Randomized controlled trial; Dupilumab; MEDLINE; Clinical trial; Minimal clinically important difference","score_opus":0.16996052305305887,"score_gpt":0.42322423949391713,"score_spread":0.25326371644085827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415851239","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.040034685,0.9542861,0.0020072516,0.00054960104,0.00038823907,0.0008388771,0.0011142202,0.0000877532,0.0006932062],"genre_scores_gemma":[0.7926384,0.19624771,0.005014774,0.001134496,0.00036822297,0.0020561875,0.0018927518,0.000085506406,0.0005619101],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9734789,0.01854417,0.0036967169,0.0022500171,0.0015865096,0.0004436559],"domain_scores_gemma":[0.9664266,0.025743555,0.004908379,0.0013113057,0.0011601791,0.00045002103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027736995,0.003158303,0.018171107,0.0050065247,0.00056630647,0.0037693062,0.0024772095,0.0025825202,0.0032640903],"category_scores_gemma":[0.041256454,0.0016794886,0.042124864,0.0044744145,0.00086787395,0.0019192374,0.0017310048,0.002186685,0.00028507566],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012437719,0.000035298388,0.0036815703,0.042113125,0.9366931,0.00005046929,0.000031533968,0.0006159437,0.00014538961,0.000080858634,0.00018537077,0.0039296644],"study_design_scores_gemma":[0.0041197552,0.00036932642,0.002461676,0.002256471,0.989504,0.000038375223,0.000022025102,0.00049546204,0.00007115359,0.00021572327,0.00042957373,0.000016433325],"about_ca_topic_score_codex":0.004287048,"about_ca_topic_score_gemma":0.006016674,"teacher_disagreement_score":0.027736995,"about_ca_system_score_codex":0.0023928462,"about_ca_system_score_gemma":0.0018091403,"threshold_uncertainty_score":0.146689},"labels":[],"label_agreement":null},{"id":"W4417274052","doi":"10.1080/09546634.2025.2588072","title":"What is the optimal sequential therapy after secondary IL-17A inhibitor failure in psoriasis: switching to an IL-23 inhibitor or to another IL-17A inhibitor?","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Drug; Enzyme inhibitor; Chemotherapy; Clinical trial","score_opus":0.023824284592163847,"score_gpt":0.2812734661010952,"score_spread":0.25744918150893137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417274052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95978653,0.030684927,0.0018136837,0.005348867,0.0001804845,0.000085477746,0.00020867775,0.000034808265,0.0018566241],"genre_scores_gemma":[0.99128586,0.0051156506,0.0019483529,0.0009745626,0.00031049683,0.000051677667,0.0001750839,0.00000964604,0.00012863104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885964,0.00039548476,0.00022900126,0.00014666482,0.00021651897,0.00015280137],"domain_scores_gemma":[0.9951439,0.0014722939,0.0021379269,0.00014759201,0.00046493096,0.00063338515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026545273,0.00017488818,0.001235003,0.00050969695,0.00043073893,0.001055101,0.00033279994,0.0007874581,0.0007880169],"category_scores_gemma":[0.006155451,0.00011985636,0.00079652003,0.0006242135,0.00041790554,0.000865988,0.00020554221,0.00070453284,0.00021097435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006067458,0.0014875499,0.64411104,0.0007756213,0.00060544064,0.0004937569,0.00029965668,0.0012320325,0.0028689206,0.00036868668,0.003243505,0.3384463],"study_design_scores_gemma":[0.0009979627,0.011338165,0.9626543,0.0018517822,0.0012634749,0.0045131557,0.001702268,0.0037435365,0.0027429622,0.0021484122,0.006961045,0.00008280327],"about_ca_topic_score_codex":0.00085132546,"about_ca_topic_score_gemma":0.0020070728,"teacher_disagreement_score":0.0026545273,"about_ca_system_score_codex":0.0005923313,"about_ca_system_score_gemma":0.0010500316,"threshold_uncertainty_score":0.014038622},"labels":[],"label_agreement":null},{"id":"W4417358255","doi":"10.1080/09546634.2025.2598183","title":"Tildrakizumab in real-world Chinese psoriasis: efficacy-safety profiles from a 28-week retrospective cohort with geriatric, late-onset and metabolic syndrome stratification","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Psoriasis; Retrospective cohort study; Metabolic syndrome; Cohort; Cohort study; Plaque psoriasis","score_opus":0.01267823375081535,"score_gpt":0.2569125784295141,"score_spread":0.24423434467869876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417358255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99955994,0.00013702472,0.00006600048,0.000010819063,0.0000016979376,0.00003138174,0.00011562234,0.0000022466534,0.00007535171],"genre_scores_gemma":[0.999342,0.00007495839,0.000078053,0.000033381817,0.000008455722,0.000033589196,0.00033812877,0.0000017575412,0.00008973279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948764,0.000102108985,0.000056814977,0.00014561927,0.0001111941,0.000096663694],"domain_scores_gemma":[0.99873346,0.00012944033,0.0005420759,0.0002177514,0.00017881565,0.00019845975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014600563,0.00045117942,0.0006043026,0.00041684345,0.0005262874,0.00043681878,0.0002627862,0.0003459248,0.0006758303],"category_scores_gemma":[0.0014471504,0.0002717045,0.000730115,0.0005610235,0.0003583856,0.00035363523,0.0003168801,0.00038591734,0.00016348997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004306136,0.000403432,0.9836374,0.00006815892,0.0004482178,0.00035749766,0.0003512793,0.00016347186,0.0040586493,0.00002883802,0.00019284834,0.005983996],"study_design_scores_gemma":[0.00029924,0.001816727,0.9956938,0.000005486205,0.00023454733,0.0005051423,0.00014266692,0.0003308395,0.0005092885,0.000018203862,0.00042915746,0.000014817684],"about_ca_topic_score_codex":0.0042506536,"about_ca_topic_score_gemma":0.0043410687,"teacher_disagreement_score":0.0042506536,"about_ca_system_score_codex":0.0006376183,"about_ca_system_score_gemma":0.00070530444,"threshold_uncertainty_score":0.008451819},"labels":[],"label_agreement":null},{"id":"W7117452601","doi":"10.1080/09546634.2025.2592448","title":"A novel nomogram based on clinical features and laboratory parameters to predict biologic-refractory psoriasis patients","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Nomogram; Psoriasis; Predictive value of tests; Clinical trial","score_opus":0.030167742732322405,"score_gpt":0.3003088606808256,"score_spread":0.27014111794850315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117452601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7692227,0.0039259656,0.2152018,0.0019830726,0.00047071616,0.0005515587,0.0031110153,0.0011157087,0.004417528],"genre_scores_gemma":[0.9723107,0.00042870457,0.024703268,0.0001533018,0.000173428,0.00021058827,0.0015221183,0.000038870116,0.00045913502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986405,0.00072159147,0.00009535619,0.00019754964,0.00025561557,0.00008940884],"domain_scores_gemma":[0.9945095,0.0034094006,0.0006607581,0.00029050838,0.0007219147,0.00040804714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048036077,0.0012860929,0.0014728212,0.003615295,0.0005194529,0.0018387003,0.0008770771,0.00075617735,0.0014445377],"category_scores_gemma":[0.011278169,0.00024398004,0.0011649987,0.0010779051,0.00042880911,0.00095701806,0.0007685265,0.0012038689,0.00044507626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020756957,0.0007902419,0.6242491,0.00023056335,0.0009670969,0.00046473116,0.0001840755,0.15361574,0.0016519347,0.0016096001,0.011294238,0.20286703],"study_design_scores_gemma":[0.00014673705,0.00039275986,0.053057045,0.00009099441,0.00028735775,0.00042426662,0.00013108455,0.940302,0.0007224049,0.0016380717,0.0027447904,0.00006260817],"about_ca_topic_score_codex":0.001808382,"about_ca_topic_score_gemma":0.0015493628,"teacher_disagreement_score":0.0048036077,"about_ca_system_score_codex":0.0005627182,"about_ca_system_score_gemma":0.0009976941,"threshold_uncertainty_score":0.025404215},"labels":[],"label_agreement":null}]}